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ABSTRACT 
 
Identification and Characterization of Genetic Factors Involved in Candida-Bacterial 
Interactions 
 
 
by 
 
Sean J. Fox  
 
Throughout existence, fungi and bacteria have long shared ecological niches and thus 
engage in numerous interactions to mutually enhance survival or antagonistically gain 
competitive advantages.  Of importance to human health are those interactions that 
involve bacteria with the opportunistic fungi, Candida albicans.  An important virulence 
factor of C. albicans is the ability to control morphology, which allows the transition 
between yeast, pseudohyphal, and hyphal phenotypes.  Morphological control in C. 
albicans is governed by quorum sensing and the secreted autoregulatory molecule 
farnesol.  Quorum sensing allows individual cells to sense the environment and respond 
as a group.  Bacteria also use quorum sensing to communicate and control virulence.  
Despite their abundance in nature, very little is known about the interactions of C. 
albicans with bacteria on a genetic and molecular level.  The objective of our research is 
to identify the genetic elements involved in C. albicans-bacterial interactions and 
characterize the genes that may participate in these relationships.  To accomplish this, 
we screened a C. albicans mutant library for the ability to filament in the presence of 
Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus, where 
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typically, these 3 bacterial species inhibit C. albicans filamentation.  We identified 836 
C. albicans mutants that displayed a filamentous phenotype in the presence of bacteria.  
Collectively, 295 of these mutants filamented in the presence of all 3 bacterial species.  
Candidates were subsequently sequenced to identify the location of the mutation and 
the affected genetic element.  CDR4, a putative ABC transporter, and ALS6, a putative 
adhesion, were further characterized for their specific involvement in Candida-bacterial 
interactions.  Using a filamentation assay, cdr4 and als6 deletion strains demonstrated a 
decreased response to the inhibitory effects of farnesol as well as bacterial molecules 
known to inhibit the production of hyphal-filaments.  Additionally, the ability of cdr4 and 
als6 deletion strains to attach and form biofilms was significantly enhanced even in the 
presence of farnesol and bacterial inhibitors.  The results of this study contribute to the 
body of knowledge involving polymicrobial interactions, and these findings may lead to 
new antifungal targets for therapeutic interventions.  
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CHAPTER 1 
INTRODUCTION 
Historically, microorganisms have been viewed as pathogens with a majority of 
the medical and scientific community’s knowledge of microbes derived from pure 
cultures.  However, rarely in the environment and the human body does one find such a 
pure culture and distinct nature of single isolated microorganisms.  In fact, the human 
body alone is inhabited by trillions of microbes representing thousands of species that 
comprise the normal flora.  These microbial communities exhibit dynamic interactions, 
express a spectrum of relationships, and employ several forms of communication.  
Research into polymicrobial interactions is quickly gaining interest due to the 
implications of the effects on both human health and disease.  However, many hurdles 
remain due to the complex nature of multispecies communities.  Understanding the 
nature of microbial interactions, biofilm formation, alterations of drug efficacy, 
phenotypic alterations, and medical implications of polymicrobial communities are 
several areas of interest.  Principal among these microbial relationships are fungal-
bacterial interactions involving the opportunistic polymorphic fungi, Candida albicans, 
the most common fungal pathogen. 
Candida albicans 
C. albicans resides as part of the normal flora in 70% of the population and can 
be isolated from the skin and gastrointestinal and genito-urinary tracts (Mavor et al. 
2005; Kim and Sudbery 2011).  While individuals with healthy immune systems can be 
affected, such as women with recurring vaginitis, those individuals with compromised or 
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suppressed immune systems face a greater risk of C. albicans transitioning from a 
commensal to deadly pathogen.  These at-risk individuals include those undergoing 
cancer treatment, HIV patients, extreme age (both the very young and very old), 
indwelling devices, and long-term antibiotic treatment (Giri and Kindo 2012).  C. 
albicans causes candidiasis of the tissue and candidemia of the bloodstream (Giri and 
Kindo 2012).  Interestingly, Nucci et al. (2001) examined the origins of candidemia and 
provided a strong case for the involvement of the human gut’s own Candida population 
as the source.  Prevalence of C. albicans, especially in the healthcare setting, is 
staggering as C. albicans is the fourth most common organism involved in  nosocomial 
blood stream infections, the third most commonly isolated organism of catheter related 
infections, and the second most common opportunistic microorganism of HIV infected 
patients (Crump and Collignon 2000; Wisplinghoff et al. 2004; Ramage et al. 2006; 
Hamza et al. 2008; Kim and Sudbery 2011;).  Mortality of C. albicans infections, 
particularly when involving the bloodstream, can reach as high as 35-40%, especially 
for patients in an intensive care unit setting (Gudlaugsson et al. 2003).  
C. albicans has numerous virulence factors at its disposal to enhance survival in 
the host for both localized and systemic infections.  These include diverse adhesins, the 
ability to form biofilms (both monospecies and polymicrobial), degradative enzymes, 
numerous drug resistance mechanisms, and lastly, which has garnered much research 
of late, the ability to change morphology (Cowen et al. 2002; Sundstrom 2002; Ramage 
et al. 2005; Schaller et al. 2005).  A number of C. albicans virulence factors can be 
linked to specific morphological states.  For example, the secreted aspartyl proteinases 
(SAP) are a group of enzymes responsible for degradation of human proteins.  While 
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Sap1p, Sap2p, and Sap3p are expressed by yeast cells, Sap4p and Sap6p are 
associated with the hyphal form (Naglik et al. 2003).  Likewise, adhesions are also 
associated with different morphologies.  Agglutin-like sequence  protein (Als3p) and 
hyphal wall protein (Hwp1p) are hyphal specific, yeast wall protein (Ywp1p) is yeast 
specific, and enhanced adhesion to polystyrene protein (Eap1p) is expressed by both 
morphological forms (Nobile and Mitchell 2006; Li et al. 2007; Liu and Filler 2011).  
Moreover, mature biofilm formation and some instances of drug resistance depend 
upon the ability of C. albicans to transition from yeast to hyphae (Baillie and Douglas 
1999).  Thus, the virulence attribute of polymorphism appears to be an ideal target for 
C. albicans research.   
Polymorphic Nature of C. albicans 
C. albicans infections and overall virulence comprises the reversible transition 
between unicellular yeast, pseudohyphal, and hyphal forms.  A variety of environmental 
factors shape morphological transition and can be induced in the laboratory via 
numerous controllable conditions.  Some of the more potent inducers of hyphal 
formation are serum, pH (neutral), temperature (37°C), and the type of media used, 
such as M199, a synthetic tissue culture media (Han et al. 2011).  Each morphological 
state is associated with specific roles in C. albicans pathogenesis and to be effectively 
virulent, it is essential for C. albicans to interconvert between morphologies (Sudbery et 
al. 2011).  The yeast morphology is necessary for initial attachment, colonization, and 
dissemination of the organism at sites of infection (Saville et al. 2003).  The hyphal form 
has the crucial responsibilities of host cell and tissue invasion as well as immune 
evasion (Shareck and Belhumeur 2011; Brand 2012;).  Infection of tissue and  access to 
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the bloodstream requires  the hyphal form to breach epithelial cells and their associated 
barriers to enter critical areas of the human body (Grubb et al. 2008, Wachtler et al. 
2012).  Hyphae are also important in escape from host immune cells, specifically 
macrophages (Lorenz et al. 2004).  When C. albicans is locked into one morphological 
form, virulence is attenuated.  For example, using a mouse model, treatment of 
systemic candidiasis was successful by inhibiting filamentation using a Candida strain 
engineered to alter its morphology based on the presence of doxycycline  (Saville et al. 
2006).  Finally, C. albicans is part of the normal flora of most immunologically 
competent individuals and the host immune system has adapted to recognize cues from 
C. albicans when it shifts from a commensal to a pathogen.  Moyes et al. (2010) 
observed that the yeast form adheres to host cells and is tolerated by the immune 
system, while a switch to hyphal morphology alerts and elicits a response from immune 
cells.  This is clear evidence that morphogenesis is important for C. albicans to colonize 
and infect the host. 
Signaling Pathways of Morphogenesis 
 C. albicans regulates its morphology in response to numerous cues perceived 
from the varied habitats in which it resides.  These cues include temperature, nitrogen 
levels, serum, amino acid availability, pH, nutrient limitations, serum, quorum sensing, 
and solid matrixes (Sudbery 2011).  Each environmental cue has an associated 
membrane detector or directly interacts with a genetic factor of the respective signaling 
system.  For instance, temperature (37°C) is sensed by the heat shock protein Hsp90p, 
amino acids are detected by the G-protein coupled receptor (Gpr1p), nitrogen levels are 
detected via the ammonium permease (Mep2p), and CO2 levels are detected through 
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the carbonic anhydrase (Nce103p) (Biswas and Morschhauser 2005; Maiden et al. 
2005; Shapiro et al. 2009; Klengel et al. 2013).  In contrast, embedded agar matrix, 
serum, and QS molecules act directly upon a component of their respective signaling 
cascade (Sudbery 2011).  Consequently, with the varied cues that C. albicans responds 
to, there are a number of signaling pathways that have been identified to control 
morphology.  Five of the most studied pathways include the cyclic AMP-protein kinase A 
(cAMP-PKA) pathway, the mitogen-activated protein kinase (MAPK) pathway, the pH 
pathway, the embedded matrix pathway, and a negative regulation of hyphae pathway.  
Each of the pathways also involve a variety of positive transcriptional regulators (Efg1p, 
Cph1p, Czf1p) and negative transcriptional regulators (Tup1p, Nrg1p, Rfg1p) of hyphal 
development (Sudbery 2011).   
Of the known pathways, the most studied and most important is the cAMP-PKA 
pathway.  This pathway controls, directly or indirectly, a number of the signals 
generated from environmental cues such as temperature, amino acids, CO2, serum, 
and nitrogen (Sudbery 2011).  Activation of cAMP-PKA occurs via the adenyl cyclase, 
Cyr1p, which funnels the signals from multiple environment cues (Rocha et al. 2001).  
Cyr1p can be activated via a Ras1p dependent or independent manner.  Ras1p is a 
membrane associated GTPase that upon physical association with Cyr1p causes an 
increase in cAMP levels (Biswas et al. 2007).  Ras1p dependent activation of Cyr1p is 
through serum, nitrogen, and temperature cues.  In contrast, independent activation of 
Cyr1p can occur through serum associated bacterial peptidoglycan, amino acid, and 
CO2 cues by directly associating with Cyr1p (Biswas et al. 2007). The ultimate target of 
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the cAMP-PKA pathway is the transcriptional factor Efg1p, which is the foremost 
positive regulator of hyphal development (Sohn et al. 2003).   
The second pathway, MAPK, is also involved in signal response to temperature, 
nitrogen, and serum (Sudbery 2011).  MAPK signaling is via Ras1p and the 
transcriptional target is the positive regulator Cph1p (Monge et al. 2006).  While the 
cAMP-PKA and MAPK pathways have a number of shared environmental triggers, as 
well as genetic signaling components, the pH pathway only shares the target 
transcriptional regulator Efg1p (Sudbery 2011).  In this pathway Rim21p, a membrane 
associated sensor, detects the pH of the environment and causes the proteolytic 
cleavage of the transcriptional regulator Rim101p that targets genes associated with 
hyphal development (Biswas et al. 2007).  Rim101p, in turn, bypasses the signaling of 
the cAMP-PKA pathway and directly regulates Efg1p (Biswas et al. 2007).  The fourth 
pathway, embedded matrix, involves the hyphal induction pathways associated with C. 
albicans when cells become embedded into agar.  This pathway is also independent of 
the cAMP-PKA and MAPK pathways and the transcriptional target is CSF1 (Sudbery 
2011).  The last pathway, negative regulation, is associated with 3 different 
transcriptional repressors of hyphal development.  Tup1p is the dominant repressor and 
has been implicated in the regulation of morphogenesis involving quorum sensing 
(Braun 1997; Kebaara et al. 2008).  The other 2 transcriptional factors, Nrg1p and 
Rfg1p, seem to work in tandem with Tup1p and even recruit Tup1p when repressing 
filamentation (Kadosh and Johnson 2001; Murad et al. 2001).  Thus, the events 
controlling C. albicans morphogenesis encompass a variety of environmental triggers 
that appear to regulate morphogenesis through multiple routes.   
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Quorum Sensing 
Microorganisms are highly adaptable and, through close contact in shared 
environments, have developed means of communicating with each other.  Cell to cell 
communication in the microbial world is a complex network that spans intraspecies, 
interspecies, and inter-kingdom interactions involving prokaryotic and eukaryotic 
microbes.  The term quorum sensing (QS) has been used to describe this 
communication process involving small secreted molecules.  QS is based on 2 main 
components, quorum sensing molecules (QSMs) and the increase in cell density of a 
population.  Microorganisms secrete QSMs into the environment and, as the cell density 
of the population increases, so do the concentration of QSMs.  Eventually, the 
population reaches a tipping point where the QSMs reach a threshold concentration.  
Once this threshold is met, the population can operate as a ‘quorum’ and activate signal 
transduction pathways to activate or repress genes responsible for a variety of 
biological functions, including motility, bioluminescence, morphology, and virulence 
(Antunes et al. 2010).  Certain criteria should be applied to differentiate QSMs from 
other molecules a microorganism emits.  These criteria include extracellular 
secretion/accrual in response to a certain change (such as cell growth), a dedicated 
receptor that recognizes the QSM, and a response by the microorganism that the QSM 
induces (Atkinson and Williams 2009).  While QS has been studied extensively in single 
species systems, relatively little is known about the cross-kingdom communication of 
QS and QSMs in the polymicrobial setting of prokaryotic-eukaryotic communities.  
Quorum Sensing in C. albicans.  The discovery of QS in C. albicans and the 
QSM farnesol  was the first documented example found in eukaryotes (Hornby et al. 
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2001).  The notion that morphology may be controlled by QSMs was observed when C. 
albicans cells were added to spent culture media, which induced this morphological 
change (Hornby et al. 2001).  The C. albicans QSM farnesol acts in a density 
dependent manner.  At concentrations below 1x106 cells/ml, C. albicans typically display 
the hyphal morphology (Kruppa 2009).  However, as the cell density increases above 
this concentration, there is an accumulation of farnesol molecules in the environment 
and the cells revert to the yeast morphology (Hornby et al. 2001).  Farnesol, at 
concentrations ranging from 10-250 µM, has the ability to inhibit the yeast to hyphal 
transition, even when C. albicans is grown under hyphal inducing conditions (Kruppa et 
al. 2004).  Farnesol at this range inhibits biofilm formation but does not affect C. 
albicans growth rate or block elongation of pre-existing hyphae (Hornby et al. 2001; 
Ramage et al. 2002).  C. albicans cells exposed to farnesol have decreased expression 
of hyphal formation associated genes, while also exhibiting an increase in drug and 
oxidative stress resistance (Cao et al. 2005; Enjalbert and Whiteway 2005; Westwater 
et al. 2005).  A number of other molecules that C. albicans secretes have been 
suggested to be additional QSMs.  However, most of these molecules either are not 
relevant at density dependent levels or produce only a small fraction of the change that 
farnesol exerts.  For example, farnesoic acid was originally reported to be a QSM and 
inhibitor of C. albicans morphogenesis but was determined to be found in only one 
particular strain (Oh et al. 2001; Hornby and Nickerson 2004).  Two other molecules, 
tryptophol and phenylethyl alcohol, were observed to have “autoantibiotic” properties by 
reducing filamentation in C. albicans (Lingappa et al. 1969).  However, the 
concentrations of the 2 molecules proved to be extremely high to mediate morphological 
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control over C. albicans (Lingappa et al. 1969).  Conversely, another QSM, tyrosol, has 
the opposite effect of farnesol.  Tyrosol can induce hyphal production in C. albicans, 
which shortens the amount of time required to induce germ tube formation of yeast cells 
(Chen et al. 2004).  This induction of hyphae can also affect the early stages of biofilm 
formation by increasing biomass (Alem et al. 2006). However, when added exogenously 
at the same time as farnesol, farnesol mutes the pro-hyphae effects of tyrosol (Alem et 
al. 2006).  Clearly, C. albicans secretes a number of factors that control its morphology, 
but farnesol is the primary regulator of the yeast to hyphal transition. 
Our understanding of QS signaling pathways in C. albicans is relatively limited 
and the receptor involved in farnesol response is unknown.  Five elements have been 
implicated as playing roles in C. albicans signaling and regulation of QS response.  
These include Ras1p, Tup1p, Cph1p, Hst7p, and Chk1p (Kruppa 2009).  Ras1p is a 
major regulator of farnesol induced response by signaling through either the cAMP-PKA 
or MAPK pathways that govern hyphal production (Leberer et al. 2001).  Tup1p, a 
transcriptional regulator, negatively regulates hyphae production in C. albicans (Braun 
1997).  Upon exposure to farnesol, TUP1 mRNA and protein levels are induced 
(Kebaara et al. 2008).  Cph1p and Hst7p are integral parts of the MAPK signaling 
cascade and mRNA of both genes are decreased in C. albicans cells that are exposed 
to farnesol (Sato et al. 2004).  MAPK signaling is heavily involved in the regulation of 
filamentation, especially in response to numerous environmental stimuli (Shapiro et al. 
2011).  Lastly, Chk1p is a histidine kinase involved in cell wall biosynthesis via a  2-
component signaling system (Kruppa et al. 2004).  CHK1 mutants exposed to farnesol 
are not responsive to the inhibitory effects and grow mainly as hyphae (Kruppa et al. 
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2004).  It is not entirely clear at this point how farnesol response signals through these 
multiple genetic elements.  
Quorum Sensing in Bacteria.  Bacterial QS and QSMs were first described in the 
bioluminescence of Vibrio fischeri and its mutualistic relationship with the bobtail squid 
(Kempner and Hanson 1968).  Since this initial discovery, the process of QS and the 
components that constitute the machinery of QS have been described in numerous 
bacterial species.  QS in bacteria can be divided into 3 different classes.  The first class 
belongs to Gram-positive bacteria, such as S. aureus, which involves small 
autoinducing peptides (AIPs) as QSMs, coupled with an accessory gene regulator (agr) 
2-component regulatory mechanism (Antunes et al. 2010).  The agr locus encodes 
agrA, agrB, agrC, and agrD (Antunes et al. 2010).  AgrD encodes the immature AIP, 
which is cleaved and secreted by the membrane bound AgrBp (Qiu et al. 2005).  When 
extracellular levels of AIP reach a sufficient level, the membrane associated AgrCp 
binds AIP and activates AgrAp through phosphorylation of ArgCp (Lina et al. 1998).  
The agrA protein then binds to target genes and induces expression of over 70 different 
genes of which 23 are associated with virulence factors (Antunes et al. 2010). 
The second class belongs to Gram-negative bacteria, such as P. aeruginosa, 
and involves homoserine lactone molecules (HSL) coupled with a LasI/LasR system 
(Antunes et al. 2010).  The LasI component makes HSL that is able to diffuse freely 
across the cell membrane (Antunes et al. 2010).  HSL molecules engage the LasR 
component, which binds to the promoter of the appropriate gene and initiates 
transcription (Antunes et al. 2010).  In actuality, P. aeruginosa has 3 different QS 
systems as well as an “orphan receptor” for QS.  In addition to the LasI/LasR QS 
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system there is a Rhl/C4HSL QS system that works much like the 3OC12HSL/Las 
system (Antunes et al. 2010).  Finally, in the Pseudomonas quinolone signal system 
(PQS) the pqsABCD operon is involved in the genesis of 2-heptyl-4-quinolone (HHQ), 
the precursor of PQS (Diggle et al. 2006).  The PQS system links the Las system to the 
Rhl system that is under the control of the Las to regulate virulence (Diggle et al. 2006; 
Dekimpe and Deziel 2009). 
Finally, the third class belongs to both Gram-positive and Gram-negative bacteria 
and is considered an interspecies QS communication pathway.  This class involves 
Autoinducer-2 (AI2) as the signaling molecule coupled with a LuxS/LuxR system 
(Antunes et al. 2010).  AI2 is synthesized by LuxS and this system has been identified 
in more than 55 bacterial species (De Keersmaecker et al. 2006).  Even bacterial 
species that do not secrete AI2 still have the ability to respond to AI2, which lends 
credence to the notion that this is a universal molecule of bacterial communication 
(Dufour and Rao 2011).  
Drug Treatment and Resistance 
C. albicans has relatively few therapeutic treatments compared to the number of 
antibiotics available for bacterial infections.  There are 4 main classes of drug 
targets/treatments for C. albicans: the azoles, polyenes, fluorocytosines, and 
echinocandins.  Each drug target/treatment has benefits and drawbacks.  The azoles, 
which include fluconazole, target the membrane by inhibiting an enzyme essential in 
ergosterol biosynthesis (Tobudic et al. 2010).  These drugs are fungistatic as they inhibit 
growth and do not actually kill C. albicans.  In cases of resistance to azoles, there are 
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several mechanisms, which include overexpression of lanosterol, an intermediate in the 
ergosterol pathway, as well as mutations that affect the binding of azoles to their targets 
(Cannon et al. 2007).  Unfortunately, because azoles are fungistatic, this can lead to 
selective survival that increase the chances of resistance (Cannon et al. 2007).  The 
polyenes, which include nystatin, target and bind to ergosterol, allowing pore formation 
in the membrane and reduces the integrity of the cell (Cannon et al. 2007).  Polyenes 
are fungicidal and resistance is rare making them very useful in the treatment of 
systemic Candida infections (Cannon et al. 2007).  When resistance occurs, it is due to 
a reduction of ergosterol in the plasma membrane (Cannon et al. 2007).  The 
disadvantage of polyenes is host toxicity, especially during prolonged use, due to the 
similarity of ergosterol to human cholesterol (Shapiro et al. 2011).  The echinocandins, 
including caspofungin, are the newest of the drug classes and inhibit cell wall 
biosynthesis, thus causing a loss in cell wall integrity (Shapiro et al. 2011).  Less is 
known about the long-term effects of echinocandins and there have been documented 
instances of drug resistance (Shapiro et al. 2011).  In all 3 drug classes, drug resistance 
is associated with modulation of the drug target, increase in drug exporters, acquired 
responses to stress, and biofilm formation (Cannon et al. 2007).  In respect to 
morphology, drug resistance and mature biofilm growth that exhibit  increased drug 
resistance require the ability to form both yeast and hyphal morphologies (Chandra et 
al. 2001).  The harmful side effects of current drugs, the increase in resistance to 
current treatments, and the lack of new antifungal targets demonstrate a need for novel 
applications of known virulence inhibitors for C. albicans. Thus, the polymorphic nature 
of C. albicans seems an attractive candidate. Targeting and controlling virulence factors 
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rather than eradicating and selecting for drug resistance may be an ideal method of 
combating C. albicans, especially because it is part of the normal flora.   
Candida-Bacterial Interactions 
The interaction of Candida with bacteria is quickly becoming an important area of 
medical research for a number of reasons.  C. albicans is normally a commensal 
organism until conditions change that benefits its growth and pathogenicity.  There is 
mounting evidence that Candida infections spawn from a person’s own normal flora 
(Wargo and Hogan 2006).  Research has implicated that the normal flora bacterial 
members, in addition to many other beneficial attributes, keep the commensal Candida 
in check (Mason et al. 2012).  When imbalances occur, as in antibiotic treatment, the 
imbalance tips the scale in favor of Candida overgrowth to transition from normal flora to 
pathogenic (Mason et al. 2012).  Secondly, Candida-bacterial interactions can be 
harmful or beneficial to the host and understanding these interactions could aid in 
human health.  Beneficial interactions include chemical and physical interactions that 
indicate bacteria can inhibit Candida virulence factors and suppress overgrowth (Boris 
and Barbés 2000).  Harmful interactions include increased mortality from polymicrobial 
infections and Candida-bacterial biofilms that intensify persistence and severity of 
infection as well as increased drug resistance (Carlson 1982; Harriott and Noverr 2009; 
Peleg et al. 2010).  Lastly, the understanding of polymicrobial interactions is, at best, in 
its infancy.  There exists a great potential for the development of new antifungals and 
antimicrobials derived from the uncharacterized world of Candida-bacterial interactions.  
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Sites of Candida-Bacterial Interactions 
Systemic Infections.  Perhaps the most dangerous form of polymicrobial 
interaction to human health involves bloodstream infections (BSI).  Once 
microorganisms gain access to the bloodstream, dissemination and infection can 
manifest in practically any part of the human body.  C. albicans is the fourth most 
common causative agent of nosocomial BSIs and 27% to 56% of C. albicans BSIs are 
polymicrobial (Wisplinghoff et al. 2004; Klotz et al. 2007).  In a study of Candida BSI 
patients, the most commonly isolated bacterial species with Candida was S. aureus 
(20%), while P. aeruginosa (8%), and E. coli (4%) were also coisolated (Klotz et al. 
2007).  Patients with bacteremia and candidemia have reduced survival rates compared 
to those with candidemia alone (Dyess et al. 1985). 
Burn Wounds.  A breach in the skin barrier is an example of trauma that can 
leave an individual at risk for microbial infections.  The principal bacterial species found 
in burns include Klebsiella, Pseudomonas, and Staphylococcus (Gupta et al. 2005).  As 
the number of bacterial species present in the burn wound increases, the presence of 
Candida decreases, suggesting an antagonistic relationship in this setting (Gupta et al. 
2005).  Pseudomonas and C. albicans are almost never co-isolated in burn wounds 
(Gupta et al. 2005).  This particular observation adds to the continuing theme of 
antagonism between P. aeruginosa and C. albicans. 
Lung/Pulmonary Tract.  Pseudomonas, Staphylococcus, and Candida species 
are 3 of the most common agents associated with ventilator-associated pneumonia 
(VAP) (Adair et al.1999).  Patients with mechanical ventilation who have colonization of 
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Candida in the respiratory tract have an increased risk of Pseudomonas VAP (Azoulay 
et al. 2006).  Ader et al. highlighted this important association as treatment of Candida 
colonization of the respiratory tract with antifungals reduces the risk of Pseudomonas 
associated VAP (Ader et al. 2008).  C. albicans co-infections may also impair the host 
immune system’s ability to deal with Pseudomonas VAP (Roux et al. 2009).  These 
observations suggest that Candida-Pseudomonas interactions in burn wounds and VAP 
are fundamentally different.  
While Candida can be found in the lungs of healthy individuals, patients with 
cystic fibrosis (CF) provide microorganisms an ideal habitat where Candida-bacterial 
interactions appear abundant.  A study of the microbial populations of the sputa of 
patients with CF found that C. albicans was present in 78% of the patients (Valenza et 
al. 2008).  Bacterial colonizers included S. aureus (63%), P. aeruginosa (50%), and E. 
coli (5%) (Valenza et al. 2008).  The population of microbes in the CF lung changes 
over time, with S. aureus associated with young children and P. aeruginosa in 80% of 
CF lungs of people in their 20s (Hauser et al. 2011).  This association with P. 
aeruginosa  also resulted in a decline in health (Hauser et al. 2011).  C. albicans 
colonization in CF patients is best predicted by the cocolonization by P. aeruginosa, and 
this cocolonization between the 2 leads to increased exacerbation of symptoms 
(Chotirmall et al. 2010).   
The Oral Cavity.  Oral colonization and infections are highly polymicrobial in 
nature.  In a study of patients with atrophic denture stomatitis, 78% of patients had 
coinfections with both S. aureus and C. albicans (Monroy et al. 2005).  In periodontal 
disease there is a strong association of Staphylococcus with Candida (Cuesta et al. 
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2010).   Of the patients who have periodontal disease, Staphylococcus species were 
found in 69.5% of the patients, while Candida species were identified in 42.7%, with the 
most common species being S. aureus and C. albicans (Cuesta et al. 2010).  In dental 
prosthesis wearers, C. albicans can be isolated from 86% and S. aureus was found in 
84% of patients with atrophic denture stomatitis (Monroy et al. 2005). 
Vaginal Infections.  Normal flora bacteria play a pivotal role in preventing C. 
albicans vaginal infections.  An estimated 75% of women will experience at least one 
vaginal infection, with about 5-10% of women having recurrent vaginal candidiasis 
(Sobel 1988).  Lactobacillus species, which constitute a majority of the vaginal 
microbiome, have been shown to have inhibitory effects on Candida and can aid in 
preventing Candida infections.  Antibiotic use disrupts this protection by destroying the 
bacterial biome allowing Candida overgrowth (Noverr and Huffnagle 2004; Strus et al. 
2005).  Fluconazole treatment in conjunction with probiotic use of Lactobacillus was 
found to aid in the treatment of vaginal candidiasis (Martinez, Franceschini et al. 2009).  
In addition, Lactobacillus has been shown to reduce the ability of C. albicans to adhere 
to and infect tissue (Martinez, Seney, et al. 2009).  
Candida Biofilms 
C. albicans biofilm formation can be divided into stages based on time and 
development.  The early stage (0-2 hours) encompasses attachment and primarily 
involves the yeast morphological form of C. albicans (Chandra et al. 2001).  The 
intermediate stage (12-30 hours) involves yeast, pseudohyphal, and immature true 
hyphae, and the final phase, maturation (38-72 hours), involves yeast, pseudohyphal, 
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and mature hyphae (Chandra et al. 2001).  The fully mature biofilm stage has 3D 
architecture, channels for fluid movement, and is encased in an extracellular matrix 
(Ramage, Martínez, et al. 2006).  Finally, the dissemination stage results in the release 
of yeast from terminal hyphae of the mature biofilm into the environment (Uppuluri et al. 
2010).  Morphological transition is important for the development of fully mature C. 
albicans biofilms.  Wild type strains of C. albicans form a normal robust biofilm with a 
thin yeast foundation layer and thick upper hyphal layers (Baillie and Douglas 1999).  
Conversely, a mutant locked in the yeast morphology could only form a yeast base 
layer, while a mutant locked into the hyphal morphology formed only an outer hyphal 
layer (Baillie and Douglas 1999).  Additionally, the locked yeast or hyphal forms show 
decreased biofilm integrity and increased antifungal drug sensitivity (Baillie and Douglas 
1999).   
Candida biofilms play a significant role in nosocomial infections associated with 
implanted devices.  Kojic et al. (2004) identified nosocomial agents associated with 
commonly implanted devices.  Candida, as the causative agent, correlated with 
vascular catheters (10%), prosthetic valves (10%), ventricular assist devices (28-66%), 
ventriculoperitoneal shunts (6-15%), and urinary catheters (10-30%) (Kojic and 
Darouiche 2004).  A second benefit of biofilms is an increase in antifungal drug 
resistance.  Fluconazole resistance in biofilms can be up to 400 times that of planktonic 
cells, with the MIC of fluconazole 128 times higher in biofilms than in planktonic cells 
(Seneviratne et al. 2008).  This increased resistance can also be found with other 
azoles and amphotericin B used to treat Candida infections (Hawser and Douglas 
1995).  Lastly, Candida-bacterial mixed biofilms have numerous benefits to the 
30 
 
microorganisms involved  including increased attachment opportunities, nutritional 
needs, stability, drug resistance, and protection from host immune defense (Adam et al. 
2002; Bamford et al. 2009; Harriott and Noverr 2009; Shirtliff et al. 2009).  For example, 
S. aureus forms poor biofilms, but when mixed with C. albicans can associate with 
hyphae and form robust biofilms (Harriott and Noverr 2009).  Additionally, P. aeruginosa 
use C. albicans biofilms to establish infection by attaching to the hyphae form and use 
them as a scaffold to form biofilms.  Whether as monospecies or polyspecies, biofilms 
have an enormous impact on human health with 65% of human infections attributed to 
biofilms (Li and Tian 2012).   
Candida-Bacterial Physical Interactions 
Candida and E. coli.  The physical interaction and type of relationship E. coli and 
C. albicans share vary depending on the aspect being examined.  In general, E. coli 
seems to have a suppressive effect on C. albicans growth.  E. coli inhibits C. albicans 
germ tube formation, but delineation of this effect, whether it be mediated by physical 
interactions, chemical interactions, or a combination of the two, has not been 
substantially examined thus far (Nair et al. 2001).  Studies involving the physical 
interactions, particularly attachment, have produced conflicting results.  For example, 
when using human cells, preincubation of E. coli significantly increased the number of 
C. albicans cells that were able to attach to human cells and it was hypothesized that E. 
coli fimbriae participated in this process (Makrides, 1983).  The same E. coli strain was 
also used in a separate study and showed an increase in C. albicans attachment to 
abiotic surfaces (Nair and Samaranayake 1996a).  Under microscopic observation, E. 
coli cells were reported to act as attachment sites for the yeast form of C. albicans (Nair 
31 
 
and Samaranayake 1996a; Nair and Samaranayake 1996b).  However, there was a 
decrease in overall C. albicans attachment when epithelial cells were preincubated with 
E. coli (Nair and Samaranayake 1996b).  Conversely, preincubation of abiotic surfaces 
with nonpathogenic  E. coli inhibited attachment of C. albicans, but it is unknown 
whether this is due to E. coli out competing C. albicans for space or due to a secreted 
factor (Trautner et al. 2010).  In a biofilm model, E. coli growth is increased when co-
cultured with C. albicans, compared to the biofilm mass of E. coli alone (Thein et al. 
2007).  There is a negative effect with a decrease in viable cell mass of C. albicans as 
the concentration of E. coli increased (Thein et al. 2007).  This study also found that 
after 48 hours, C. albicans blastospores and a majority of hyphae were nonviable, but 
E. coli remained viable in dual species biofilms (Thein et al. 2007).  These results 
indicate that the interactions between E. coli and C. albicans vary depending upon a 
series of factors such as which microorganism is in greatest concentration, which 
attaches first, and how the relationship evolves over time. 
Candida and P. aeruginosa.  Arguably, the majority of research into Candida-
bacterial relationships has centered on the interactions of C. albicans with P. 
aeruginosa, which seem to have an antagonistic relationship.  Hogan et al. found that 
when coincubated P. aeruginosa was able to attach to, form biofilms on, and ultimately 
kill C. albicans hyphae (Hogan and Kolter 2002).  In contrast, P. aeruginosa was unable 
to attach to yeast cells, which retain their viability (Hogan and Kolter 2002).  
Subsequently, a number of factors were identified that were required for P. aeruginosa 
interactions with C. albicans hyphae (see Table 1.1).  Type IV pili of P. aeruginosa 
appear necessary for physical interactions with C. albicans, as type IV pili mutants are 
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attenuated in their attachment to hyphae and have delayed killing time (Hogan and 
Kolter 2002).  Additionally, the presence of bacteria was required for the killing of C. 
albicans hyphae, whereas bacterial media alone did not have this effect (Hogan and 
Kolter 2002).  However, another study showed that cell free bacterial media alone can 
kill hyphae but not as effectively as live bacteria (Brand et al. 2008).   
Another factor involved in the physical interaction and killing by P. aeruginosa is 
the glycosylation status of the C. albicans cell wall (Brand et al. 2008).  C. albicans 
strains that have defects in O-linked glycosylation were more susceptible to P. 
aeruginosa contact mediated cell death, suggesting that cell wall glycans play a role in 
attachment as well as cell viability (Brand et al. 2008).  Cell death may also be linked to 
attachment.  Brand et al. found that C. albicans cell lysis occurs at points of P. 
aeruginosa microcolony attachment (Brand et al. 2008).  This suggests that contact 
dependent factors play a role in the antagonistic relationship of P. aeruginosa and C. 
albicans.  In mixed Candida-Pseudomonas biofilms, competitive attachment is 
prevalent.  In a study of attachment and biofilm growth in mixed biofilms, the ability to 
produce glycocalyx affected Candida-Pseudomonas interactions (El-Azizi et al. 2004).  
Glycocalyx deficient P. aeruginosa biofilms reduced the attachment and biofilm growth 
of C. albicans, while glycocalyx positive P. aeruginosa biofilms increased C. albicans 
attachment (El-Azizi et al. 2004).  Conversely, C. albicans preformed biofilms enhanced 
the adhesion and biofilm growth of nonglycocalyx producing P. aeruginosa (El-Azizi et 
al. 2004).  When bacteria and C. albicans were added simultaneously, there was a 
decrease in C. albicans attachment despite the glycocalyx status of the P. aeruginosa 
(El-Azizi et al. 2004).  The antagonistic relationship between C. albicans and P. 
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aeruginosa can also be seen over the course of biofilm growth.  P. aeruginosa exudes a 
suppressive effect on C. albicans during the attachment phase (57% reduction), 
maturation phase (67% reduction), and fully mature biofilms (99% reduction) (Bandara 
et al. 2010).  Candida-Pseudomonas interactions continue to be the most studied 
polymicrobial interactions due to their opposing effects upon each other and serve as a 
template for eukaryotic-prokaryotic relationships. 
Candida and S. aureus.  C. albicans and S. aureus appear to have a mutualistic 
relationship, with S. aureus being the third most common microorganism coisolated in 
polymicrobial C. albicans bloodstream infections (Klotz et al. 2007).  This synergism and 
accompanying physical interactions are best observed in mixed Candida-S. aureus 
biofilms.  S. aureus preferentially associates and forms colonies on hyphae without 
harming  the viability of hyphae as with P. aeruginosa coculture (Harriott and Noverr 
2009; Harriott and Noverr 2010; Peters et al. 2010).  C. albicans also confers the ability 
of S. aureus to form biofilms in serum, where typically it cannot, while also protecting S. 
aureus from antibiotics (Harriott and Noverr 2009).  It is hypothesized that C. albicans 
encases S. aureus in an extracellular matrix, thereby obstructing the effects of 
antibiotics on the bacteria (Harriott and Noverr 2009).  S. aureus attachment is 
strongest at the tip and middle of C. albicans hyphae with weaker attachment to S. 
aureus to yeast cells (Ovchinnikova et al. 2012).  Using mutants deficient in hyphal 
production, it was shown that morphogenesis is instrumental in the ability of S. aureus 
to form mixed biofilms with C. albicans (Harriott and Noverr 2010).  Only mutants that 
have the ability to attach to abiotic surfaces can increase antibiotic resistance of S. 
aureus (Harriott and Noverr 2010).  Using atomic force microscopy in conjunction with 
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C. albicans mutants, Peters et al. found that Als3p proved to be a significant player in 
the attachment of C. albicans to S. aureus (see Table 1.1) (Peters et al. 2012).  The 
expression of Als3p in S. cerevisiae allowed the binding of S. aureus, to which it 
normally cannot attach (Peters et al. 2012).  The most interesting finding involving 
physical interactions of C. albicans and S. aureus is the synergistic tissue invasion of 
coinfections.  S. aureus, which normally cannot invade tissue, appears to use C. 
albicans hyphae to gain tissue access.  In murine tongues it was shown that S. aureus 
could only penetrate the tissue when attached to the hyphal form of C. albicans and 
abolishing C. albicans Als3p negated this effect (Peters et al. 2012).  Attachment most 
likely involves other factors yet to be identified.  While live C. albicans cells are not 
necessary for S. aureus to form biofilms, heat inactivated or formalin exposed C. 
albicans cannot support S. aureus attachment/biofilm growth, indicating additional 
Candida surface components are involved (Harriott and Noverr 2010).  Morphology also 
plays a role in the relationship between C. albicans and S. aureus.  In C. albicans 
hyphal biofilms there is an upregulation of S. aureus proteins associated with 
metabolism and protein synthesis (Peters et al. 2010).  However, in yeast biofilms, S. 
aureus induces protein expression related to cell stress response in C. albicans (Peters 
et al. 2010).  The factors of C. albicans morphogenesis, hyphal association, biofilm 
formation, and antibiotic resistance all form new perspectives on the importance of 
understanding Candida-S. aureus coinfections and the importance of understanding the 
physical interactions of the 2 microorganisms.   
Other Important Candida – Bacterial Interactions.  Acinetobacter baumannii  
inhibits C. albicans filamentation by attaching to the hyphal form, leading to the death of 
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filaments, but leaves yeast cells viable (Peleg et al. 2008).  An outer membrane protein, 
ompA, of A. baumannii is involved in attachment to C. albicans and necessary for the 
killing of hyphae (see Table 1.1) (Gaddy et al. 2009). Salmonella enterica serovar 
typhimurium adheres to C. albicans filaments causing filament death (Kim and 
Mylonakis 2011).  In contrast to A. baumannii and S. typhimurium, Streptococcus 
gordonii appears to share a mutualistic relationship with C. albicans by aiding in the 
colonization of the oral cavity by promoting hyphal formation of C. albicans (Bamford et 
al. 2009).  There are a number of factors involved in attachment of S. gordonii to C. 
albicans, including cell surface polypeptides and salivary adhesions (Holmes et al. 
1996).  C. albicans adhesin proteins have been shown to be required for S. gordonii 
attachment, namely Als3p, Eap1p, and Hwp1p (Nobbs et al. 2010).  S. gordonii SspB, 
of the antigen family peptides, attaches to C. albicans Als3p (Bamford et al. 2009; 
Silverman et al. 2010).  S. gordonii takes up salivary proteins and displays them on their 
surface that C. albicans can use for attachment  (O’Sullivan et al. 2000).  Another 
Streptococcus species, S. mutans, uses glucosyltransferases to attach to C. albicans 
(Gregoire et al. 2011).  S. salivarius attaches to and covers C. albicans hyphae (Ishijima 
et al. 2012).   
Table 1.1 Attachment factors associated with Candida-bacterial interactions. 
Microorganism Proposed Attachment Factors 
Attachment 
Reference 
Yeast Hyphae 
Acinetobacter 
baumannii 
A. baumannii: ompA Limited Yes (Gaddy et al. 2009) 
Escherichia 
coli 
E. coli: Unknown (fimbriae?) Yes ? 
(Makrides, 1983, 
Microbios) 
Pseudomonas 
aeruginosa 
P. aeruginosa: Unknown (pili?) 
C. albicans: Unknown  
(Glycoproteins?) 
No Yes 
(Hogan and Kolter 
2002; Brand et al. 
2008) 
Salmonella S. enterica: sopB Limited Yes (Kim and Mylonakis 
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Candida-Bacterial Chemical Interactions 
Candida and E. coli.  Chemical interactions between E. coli and C. albicans 
remain ill defined.  E. coli is known to use the QSM AI2, but when Bandara et al. 
examined the effect of AI2 on a panel of Candida species in regards to biofilm growth, 
there was to be no effect on C. albicans (Bandara 2011).  A relatively new QSM, AI3, 
and associated QS system has been described in E. coli; however, the signaling 
pathways and the resulting effects on virulence are still being investigated (Antunes et 
al. 2010).  It is quite possible E. coli, given its overwhelming abundance in the human 
body, exudes a number of other QSMs or chemical metabolites that are unknown at this 
time.    
Bacterial lipopolysaccharide (LPS) may serve as a communication messenger 
between bacteria and Candida.  In a study of E. coli LPS on biofilm formation, there was 
no effect on C. albicans biofilms, but it did have effects on other Candida species 
(Bandara et al. 2009).  In vivo, E. coli LPS injected into mice along with C. albicans 
have a number of effects including increased virulence and increased number of cells in 
tissue (Akagawa et al. 1995; Henry-Stanley et al. 2003).  
typhimurium 2011) 
Staphylococcus 
aureus 
C. albicans: Als3p Yes Yes (Peters et al. 2012) 
Staphylococcus 
epidermidis 
Unknown Yes Yes (Adam et al. 2002) 
Streptococcus 
gordonii 
S. gordonii: cshA, cshB, sspA, 
sspB 
C. albicans: Als3p, Eap1p, Hwp1p 
Yes Yes 
(Bamford et al. 
2009; Nobbs et l. 
2010) 
Streptococcus 
mutans 
S. mutans: Glucosyltransferase B Yes ? 
(Gregoire et al. 
2011) 
Streptococcus 
salivarius 
Unknown Limited Yes 
(Ishijima et al. 
2012) 
Table 1.1 (continued) 
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Candida and P. aeruginosa.  P. aeruginosa has an arsenal of secreted molecules 
and metabolites at its disposal, of which many have been shown to influence C. 
albicans (see Table 1.2).  Hogan et al. demonstrated that P. aeruginosa mutants with 
genetic defects in secreted factor genes, such as PlcS and PlcR (phopholipase C), 
PhnAB (phenazines), GacA (HSL and pyocyanin), LasR (QS molecules), RhlR (QS 
molecules), and RpoN (QS response) are attenuated in the killing of C. albicans hyphae 
(Hogan and Kolter 2002).  Hogan et al. (2004) also identified P. aeruginosa genes 
essential in inhibition of C. albicans morphological changes, including genes (lasL, lasR, 
rhlL, rhlR) involved in the secretion of HSL molecules.  This led to the identification of 3-
oxo-C12 homoserine lactone (3OC12HSL), a QSM of P. aeruginosa, as having a 
significant effect on C. albicans morphology (Hogan et al. 2004).  Purified 3OC12HSL 
inhibits C. albicans filamentation, reverts preformed filaments back to the yeast form, 
induces expression of yeast genes, and  decreases expression of hyphal genes (Hogan 
et al. 2004).  Testing a battery of similar molecules, it was found that this effect on C. 
albicans filamentation was linked to a similar 12 carbon chain structure that is shared 
between 3OC12HSL and the C. albicans QSM farnesol (Hornby et al. 2001; Hogan et 
al. 2004).  HSL production is strain specific among P. aeruginosa and media from HSL 
producing strains is able to inhibit  C. albicans morphological transition, while inhibition 
is not found with reduced HSL producing strains (McAlester et al. 2008).  In contrast, 
supernatants from P. aeruginosa HSL producers and nonproducers inhibited C. 
albicans biofilm formation at the maturation phase but not at other biofilm stages 
(Holcombe et al. 2010).  Gene expression of C. albicans biofilms exposed to P. 
aeruginosa supernatant from both HSL producing and non-HSL producing strains affect 
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different genes but also regulate expression of an overlapping 238 genes (Holcombe et 
al. 2010; Reen et al. 2011).  HHQ, a precursor to PQS, inhibits C. albicans biofilm 
formation without affecting adhesion or morphology (Reen et al. 2011).  Phenazines 
also reduce C. albicans viability, ability to produce hyphae, attachment, alter 
metabolism, and influence biofilm formation (Morales et al. 2013).  P. aeruginosa cis-2-
decenoic acid induces C. albicans biofilm dispersion, as well as that of many other 
bacterial biofilms (Davies and Marques 2009).  Pyocyanin and 1-hydroxyphenazine 
inhibit C. albicans growth and pyocyanin treated C. albicans cells lack hyphal 
development (Kerr et al. 1999).  Taken together, the numerous molecules involved in 
Candida-Pseudomonas interactions highlight the steps each microorganism will take to 
gain an advantage. 
Candida and S. aureus.  Although S. aureus and C. albicans have a number of 
intricate physical associations, particularly with the hyphal form, and are found together 
in numerous areas of the human body, relatively little is known about their chemical 
interactions.  While S. aureus employs a peptide system of QS, to date these AIPs have 
not been tested for influence on C. albicans.   
Other Notable Candida-Bacterial Chemical Interactions.  Acinetobacter 
baumannii spent bacterial media from the stationary phase growth inhibits C. albicans 
filamentation and biofilm growth but not to the same extent of live cells (Peleg et al. 
2008).  A. baumannii implements a LuxI autoinducer system, but mutations in LuxI do 
not inhibit filamentation (Peleg et al. 2008).  However, a mutant of the A. baumannii 
gacS sensor kinase has reduced filament inhibition and cell death of C. albicans, 
indicating secreted molecules may play a role in this process (Peleg et al. 2008).  
39 
 
Xanthomonas campestris produces a diffusible signal factor (DSF), cis-11-
methyl-2-dodecenoic acid, that acts as a signaling molecule to control virulence (Wang 
et al. 2003).  DSF is similar structurally to farnesol and can inhibit the yeast to hyphal 
shift in C. albicans albeit with less potency (Wang et al. 2003). 
Burkholderia cenocepacia produces a signal molecule very similar to X. 
campestris DSF and structurally similar to the C. albicans QSM (Zhang et al. 2011)  
This signal molecule, cis-2-dodecenoic acid (BDSF), is a potent inhibitor of C. albicans 
germ tube formation with stronger inhibitory effects than that of farnesol, HSL, and DSF, 
(Boon et al. 2008).  Zhang et al. expanded on these findings and found that BDSF is an 
effective inhibitor of C. albicans biofilm formation but has limited effects on preformed 
biofilms (Zhang et al. 2011).  Also, BDSF greatly reduces the expression of hyphal 
specific genes HWP1 and ALS3 (Zhang et al. 2011). 
Enterococcus faecalis supernatant inhibits C. albicans filamentation in a 
Caenorhabditis elegans model, while also inhibiting biofilm formation, but does not 
seem to kill C. albicans (Cruz et al. 2013).  E. faecalis uses small peptides as QSMs, 
GBAP, and the Fsr QS system. GBAP does not seem to be involved, but the Fsr system 
does play a role in the inhibitory effects on C. albicans (Cruz et al. 2013).   
Streptococcus mutans secretes a number of molecules that have effects on C. 
albicans.  The first molecule shown to influence C. albicans was trans-2 decenoic acid, 
which shares similar structure to farnesol and X. campestris DSF, thus was given the 
name Streptococcus diffusible factor (SDSF) (see Table 1.2) (Vílchez et al. 2010).  
SDSF from stationary cultures inhibits C. albicans hyphal formation, but, this effect is 
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only observed at 2 and 4 hours of incubation and dissipates after 6 hours (Vilchez et al. 
2010).  SDSF was also able to reduce the expression of hyphal specific genes HWP1 
and SAP5 (Vílchez et al. 2010).  Researchers found that SDSF production was not 
limited to S. mutans but also found in S. sanguinis, S. oralis, and S. mitis (Vílchez et al. 
2010).  Another molecule produced by S. mutans, mutanobactin A, has been shown to 
inhibit the yeast to hyphal morphological shift (Joyner et al. 2010).  S. mutans can inhibit 
germ tube formation even when physically separated from C. albicans.  Spent media 
from 4 hours inhibits germ tube formation, but 6, 8, and 24 hour does not (Jarosz et al. 
2009).  Competence stimulating peptide (CSP), a 22 amino acid peptide, acts as a QSM 
of S. mutans and is produced in the beginning of exponential growth phase (Jarosz et al 
2009).  Mutants of comC that encodes CSP could not reproduce this inhibition (Jarosz 
et al. 2009).  CSP does not inhibit growth nor evoke stress response or significantly  
inhibit biofilm formation (Jarosz et al. 2009).  Other Streptococcus species tested had 
varying effects similar to S. mutans (Jarosz et al. 2009). 
Indole is a molecule shared among both Gram-positive and Gram-negative 
bacteria that is hypothesized to be a QSM of E. coli used in the communication of 
biofilm populations (Lee and Lee 2010).  Raut et al. observed that physiologically 
relevant levels of indole inhibited C. albicans growth, germ tube formation, adhesion, 
and  blocked biofilm formation (Raut et al. 2012).  Oh et al. (2012) found that indole was 
able to reduce the attachment of C. albicans to human epithelial cells at concentrations 
that did not affect the viability of human cells.  Additionally, in a C. elegans model, 
indole was able to inhibit filamentation, increase survival of the worm, and led to an 
overall lower C. albicans burden (Oh et al. 2012).  When examining the effects of indole 
41 
 
on C. albicans gene expression it was unexpectedly found that genes that are normally 
affected by bacterial influences on C. albicans virulence, most notably ALS3 and HWP1, 
were unaffected; however, NRG1, a transcriptional repressor of filamentation, was 
greatly increased (Oh et al. 2012).    
Peptidoglycan (PPG) constitutes the cell wall of both Gram-positive (in large 
amounts) and Gram-negative bacteria (in smaller amounts).  Xu et al. (2008) found that 
PPG from E. coli and S. aureus did not alter C. albicans morphogenesis, but when PPG 
is hydrolyzed it can promote hyphal morphology.  The subunit of PPG that was shown 
to be the active inducer of hyphae was muramyl dipeptide (Xu et al. 2008).  Purified and 
synthetic muramyl dipeptides interact with Cyr1p and Ras1p for the signaling of hyphal 
development (Xu et al. 2008).  Serum, depending on the source, is a potent inducer of 
hyphae and PPG can be readily found in serum (Xu et al. 2008).   PPG is also found in 
the intestines where C. albicans may use it to induce filamentation for invasion (Xu et al. 
2008).   
Lipopolysaccharides (LPS), large lipid polysaccharides, are major constituents of 
Gram-negative bacterial membranes.  As mentioned previously, E. coli LPS has no 
effect on C. albicans biofilms but has varying effects on other Candida species 
(Bandara et al. 2009).   Bandara et al. (2010) also examined different bacterial LPS 
effects on biofilm growth using a number of different Candida species, again finding that 
the effect is Candida species specific.  Serratia marcescens, and Salmonella 
typhimurium LPS had no significant changes in C. albicans biofilms at any stage 
(Bandara et al. 2010).  P. aeruginosa LPS significantly  increased C. albicans metabolic 
activity during biofilm attachment (0-90 minutes) phase, with increases in yeast cell 
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numbers as well as the presence of numerous dead C. albicans cells (Bandara et al. 
2010).  Klebsiella pneumonia LPS also produced significant increases in metabolic 
activity at both the attachment and maturation (90 min-24 hours) of C. albicans biofilms 
(Bandara et al. 2010).  The overall message was that LPS from different bacterial 
species affect different Candida species in different ways in a time, concentration, and 
species dependent manner (Bandara et al. 2010).  Generally, higher concentrations of 
LPS from both bacteria inhibited C. albicans metabolic activity, while lower 
concentrations enhanced metabolic activity (Bandara et al. 2013).  P. aeruginosa LPS 
resulted in increased yeast cell morphology and decreased hyphal cell morphology in 
biofilms with “patchy” architecture, but the cells were still viable (Bandara et al. 2013).  
LPS from both P. aeruginosa and K. pneumonia increased expression of hyphal specific 
genes and P. aeruginosa LPS inhibited protein synthesis in C. albicans (Bandara et al. 
2013).  One factor that could explain the varying effects of LPS on C. albicans could be 
the small differences in LPS structure between strains as well as differences between 
species. 
Lactobacillus rhamnosus bacteria inhibit C. albicans germ tube formation, while 
heat killed bacteria are unable to (Nover and Huffnagle 2004).  Bacterial supernatant 
from 2 hour (30-55%) and 24 hour (92-98%)  growth of L. casei, L. paracasei, and L. 
rhamnosus all inhibited germ tube formation (Noverr and Huffnagle 2004).  Noverr et al. 
tested a number of short chain fatty acids readily produced by Lactobacillus and butyric 
acid, inhibited in a concentration dependent manner (Noverr and Huffnagle 2004).  
When gene expression is examined in C. albicans-Lactobacillus coculture there are 
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changes drug exporters, stress responses, transport, signal transduction, and targets of 
fluconazole gene expression (Köhler et al. 2012). 
Streptococcus gordonii stationary phase media can induce hyphal formation in C. 
albicans, but a S. gordonii luxS mutant, with a deletion for AI2 QS, cannot produce the 
induction of hyphae (Bamford et al. 2009).  Precursors of AI2 used to mimic AI2 could 
not rescue the lux2 mutant’s ability to induce hyphae in C. albicans (Bamford et al. 
2009).  Thus, either  the precursors of AI2 used in this experiment are a poor substitute 
or there are other secreted factors causing hyphal induction (Bamford et al. 2009).  
Salmonella typhimurium media from stationary growth inhibits C. albicans 
filamentation, whereas media from exponential growth does not (Tampakakis et al. 
2009).  There is no known QSM associated with S. typhimurium; however, it does have 
a QS sensor sdiA that can respond to other bacterial QSMs (Tampakakis et al. 2009).  
Supernatant form S. typhimurium stationary growth suppresses C. albicans TEC1, 
HWP1, ALS3, and CDC42 gene expression (Tampakakis et al. 2009).   
Table 1.2 Bacterial molecules associated with Candida-bacterial interactions. 
Microorganism Proposed Molecule(s) 
Effect on  
C. albicans 
Reference 
Acinetobacter  
baumannii 
Unknown Inhibitory (Peleg et al. 2008) 
Burkholderia  
cenocepacia 
Dodecenoic acid 
  
Inhibitory (Zhang et al. 2011) 
Escherichia  
coli 
Unknown Inhibitory (Nair et al. 2001) 
Lactobacillus  
rhamnosus 
Butyric acid Inhibitory (Noverr and Huffnagle 2004) 
Pseudomonas  
aeruginosa 
HSL, HHQ, Decenoic acid, 
Pyocyanin, Phenazine 
Inhibitory 
(Kerr et al. 1999; Hogan et al. 
2004; Davies and Marques 2009) 
Salmonella 
typhimurium 
Unknown Inhibitory (Tampakakis et al. 2009) 
Staphylococcus  
aureus 
Unknown 
Inhibitory 
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Streptococcus  
gordonii 
AI-2 Enhancing (Bamford et al. 2009) 
Streptococcus  
mutans 
Decenoic acid, CSP  
Mutanobactin A 
Inhibitory 
 
(Jarosz et al. 2009; Joyner et al. 
2010; Vílchez et al. 2010) 
Xanthamonas  
campestris 
Dodecenoic acid Inhibitory (Wang et al. 2003) 
Various bacteria Indole Inhibitory (Raut et al. 2012) 
Various bacteria LPS Varying (H.M.H.N. Bandara et al. 2010) 
Various bacteria PPG subunits Enhancing (Xu et al. 2008) 
 
Farnesol’s Effect on Bacteria 
Farnesol has numerous observed effects on several bacteria (see Table 1.3).  
For instance, swarming motility of P. aeruginosa is inhibited by farnesol (McAlester et al. 
2008).  Additionally, farnesol inhibits the production of PQS in P. aeruginosa, which 
directly inhibits pyocyanin production (Cugini et al. 2007).  This action can be 
suppressed by higher levels of PQS (Cugini et al. 2007).  Cugini et al. (2010) also found 
that P. aeruginosa strains defective in the LasR QS system and PQS production can be 
restored by the addition of farnesol resulting in increased pyocyanin and phenazine 
production. 
Farnesol is able to compromise S. aureus and S. epidermidis membrane integrity 
and sensitize them to antimicrobials (see Table 1.3) (Meiller et al. 2006; Pammi et al. 
2012).  In S. aureus biofilms extremely high concentrations of farnesol (30mM) are able 
to inhibit formation, reduce the number of viable bacteria, and prevent further growth of 
preformed biofilms (Unnanuntana et al. 2009).   
When C. albicans establishes a quorum, after 8 hours of biofilm growth, it is able 
to inhibit A. baumannii growth (Peleg et al. 2008).  Synthetic farnesol added to media 
Table 1.2 (continued) 
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also inhibited A. baumanii growth and mutants defective in farnesol production are 
unable to inhibit A. baumannii (Peleg et al. 2008).  
Finally, S. mutans membrane permeability is hindered in the presence of farnesol 
(Jeon et al. 2011).  Additionally, when applied to mixed species biofilms of commonly 
found oral bacteria, farnesol inhibits the competitiveness of S. mutans and reduces its 
dominance over other species in the polymicrobial biofilms (Jeon et al. 2011). 
In polymicrobial communities of bacteria and Candida there is a microbial chess 
match to gain a competitive advantage for limited resources and space.  Often, with 
every movement by one microorganism, especially when involving chemical molecules, 
there is a counter move made by the competing microorganism.  Farnesol appears to 
serve as both a regulator of C. albicans morphogenesis as well as a chemical counter 
attack to bacterial competitors.  
Table 1.3 Reported effects of Candida albicans farnesol on bacteria. 
Bacteria Effect of Farnesol on Bacteria Reference 
Acinetobacter  
baumannii 
Inhibits growth (Peleg et al. 2008) 
Escherichia  
coli 
Increases antibiotic sensitivity 
 
(Brehm-stecher and Johnson 
2003) 
Pseudomonas  
aeruginosa 
Inhibits PQS, pyocyanin, swarming 
motility 
(Cugini et al. 2007; McAlester et 
al. 2008; Cugini et al. 2010) 
Staphylococcus  
aureus 
Compromises cell membrane integrity, 
Increases antibiotic sensitivity 
(Meillereet al. 2006) 
Staphylococcus  
epidermidis 
Compromises cell membrane integrity, 
Increases antibiotic effectivity 
(Pammi et al. 2012) 
Streptococcus  
mutans 
Compromises membrane integrity, 
Prevents biofilm dominance 
(Jeon et al. 2011) 
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Specific Aims 
Recent research has shown that C. albicans can respond to bacterial QS 
molecules (Hogan and Kolter 2002; Boon et al. 2008; Peleg et al. 2008).  In addition to 
QSMs, bacteria secrete metabolites, antibiotics, and other molecules into their 
environment that could also be types of communication.  This would imply that there are 
signaling or genetic pathways that C. albicans uses to detect bacterial QSMs, as well as 
other metabolites, that regulate C. albicans ability to filament.  Thus, we hypothesize 
that C. albicans uses more than one pathway to regulate filamentation in the presence 
of bacteria.  In many instances bacteria can inhibit the ability of C. albicans to change its 
morphology, thus inhibiting the yeast to hyphal shift (Hogan and Kolter 2002; 
Tampakakis et al. 2009).  The understanding of this process and the pathways involved 
has, thus far, not been defined.  Only a single gene CHK1 has been shown to be 
genetically linked to C. albicans QS, which cannot account for all modes Candida-
bacterial interactions (Kruppa et al. 2004).  To better characterize this process, the 
implementation of a genetic screen to aid in the identification of genes that are involved 
in the regulation of C. albicans ability to filament in the presence of Gram-positive and 
Gram-negative bacteria could prove very useful.  This would allow for identification of 
common as well as bacteria-specific linked genes/pathways that modulate filamentation 
of C. albicans.   
AIM 1:  Screen a C. albicans transposon insertion library to identify candidates that 
filament in the presence of bacteria and identify the insertion site of the transposon 
within the C. albicans genome (Chapter 2). 
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AIM 2: Characterize the involvement of C. albicans CDR4 in the regulation of 
filamentation in the presence of bacteria (Chapter 3). 
AIM 3: Characterize the involvement of C. albicans ALS6 in the regulation of 
filamentation in the presence of bacteria (Chapter 3). 
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Abstract   
In the human body, fungi and bacteria share many niches where the close contact of 
these organisms maintains a balance among the microbial population.  However, when 
this microbial balance is disrupted, as with antibiotic treatment, other bacteria or fungi 
can grow uninhibited.  C. albicans is the most common opportunistic fungal pathogen 
affecting humans and can uniquely control its morphogenesis between yeast, 
pseudohyphal, and hyphal forms.  Numerous studies have shown that C. albicans 
interactions with bacteria can impact its ability to undergo morphogenesis; however, the 
genetics that govern this morphological control via these bacterial interactions are still 
relatively unknown.  To aid in the understanding of the cross-kingdom interactions of C. 
albicans with bacteria and the impact on morphology we utilized a haploinsufficiency 
based C. albicans mutant screen to test for the ability of C. albicans to produce hyphae 
in the presence of three bacterial species (Escherichia coli, Pseudomonas aeruginosa, 
and Staphylococcus aureus).  Of the 18,144 mutant strains tested, 295 mutants 
produced hyphae in the presence of all three bacterial species.  The 295 mutants 
identified 132 points of insertion, which included identified/predicted genes, major 
repeat sequences, and a number of non-coding/unannotated transcripts.  One gene, 
CDR4, displayed increased expression when co-cultured with S. aureus, but not E. coli 
or P. aeruginosa.  Our data demonstrates the ability to use a large scale library screen 
to identify genes involved in Candida-bacterial interactions and provides the foundation 
for comprehending the genetic pathways relating to bacterial control of C. albicans 
morphogenesis.   
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Introduction 
 
Polymicrobial communities of bacteria and fungi play a pivotal role in both human health 
and disease and  can be found on nearly all facets of the human body including the 
skin, mouth, lungs, gastrointestinal, urinary, and reproductive tracts [1].  As varied as 
the habitats these microbes reside in are the types of interactions (both chemical and 
physical) that the opportunistic fungal pathogen Candida albicans and bacteria have 
with one another, which are only recently being fully appreciated by the scientific 
community [1,2].  C. albicans ability to change morphology from a budding yeast to a 
filamentous hyphae is considered a major virulence factor [3,4] that is influenced 
through a variety of environmental and host factors, including temperature, serum, pH, 
nutrient availability, and quorum sensing (QS) [5].  QS in C. albicans is regulated by the 
molecule farnesol [6], which when present at saturating levels, inhibits the ability of C. 
albicans to shift from yeast to hyphal form.  This type of chemical communication 
among a population has also been well documented in bacteria [7–10].  Recent 
research has shown that bacterially secreted quorum sensing molecules (QSMs) and 
other metabolites can influence C. albicans morphology as well.  For example, 
Pseudomonas aeruginosa secretes the QS molecule (QSM) 3-oxo-C12 homoserine 
lactone (3OC12HSL) that can block C. albicans filamentation [11]. Likewise, 
Burkholderia cenocepacia’s diffusible signal molecule, cis-2 dodecenoic acid, has been 
shown to inhibit C. albicans germ tube formation [12].  Similar inhibitory effects can be 
observed when C. albicans interacts with the bacteria Acinetobacter baumannii and 
Streptococcus mutans or the yeast Saccharomyces boulardii [13–15].  Interestingly, 
different bacterial species from the same genus, as in the case of Streptococcus, can 
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have opposing effects on C. albicans morphology.  For instance, the oral bacterium S. 
mutans inhibits hyphal formation of C. albicans via the QSMs trans-2-decenoic acid and 
competence stimulating peptides [14,16]; however, S. gordonii appears to stimulate C. 
albicans hyphae formation in an effort to aid in the colonization of the oral cavity [17].  
These results suggest that C. albicans has mechanisms in place that can recognize 
these bacterial molecules in the environment and respond accordingly.   
Physical interactions between bacteria and C. albicans include both attachment 
and the development of mixed species biofilms on both biotic and abiotic surfaces [18].  
In addition to P. aeruginosa secretion of 3OC12HSL, the bacterium preferentially 
attaches to and kills the C. albicans hyphal form, but not the yeast form [19].   
Alternatively, Staphylococcus epidermidis enjoys the ability of attaching to both the 
yeast and hyphal forms of C. albicans, and when found together as in a mixed biofilm, 
enhances C. albicans resistance to fluconazole [20].  Additionally, S. aureus 
preferentially attaches to C. albicans hyphae and these mixed biofilms show increased 
drug resistance to Vancomycin [21–23].  On the other hand, farnesol has been shown to 
disrupt S. aureus membrane integrity making it more susceptible to antibiotics as well 
as interfering with biofilm growth [24].  From a virulence standpoint, co-infection of C. 
albicans and other bacterial species, including S. aureus, E. coli and P. aeruginosa, 
show synergy with increased mouse mortality when the organisms are infected at 
sublethal doses [23,25–28].  Furthermore, prior colonization of  E. coli in the urinary 
tract enhances C. albicans ability to colonize and subsequently cause urinary tract 
infections where typically it is unable to do so [29].  These trans-kingdom interactions 
may indicate that microorganisms utilize the nearby molecules to sense and monitor 
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their shared surrounding, adapt to changes in the local environment, and survive within 
a mixed species population.  Despite the recent influx of research into Candida-bacterial 
interactions little is known about the genetics behind the mechanisms of communication 
that govern these interactions, and how they control morphological change in C. 
albicans. 
Multiple species of bacteria are known to inhibit C. albicans filamentation and our 
goal was to identify mutants that did not respond when cultured in the presence of 
bacteria.  In the present study, we utilized a large scale haploinsufficiency based screen 
to identify the genetic elements regulating C. albicans filamentation in the presence of 
bacteria.  To our knowledge, this screen is the first to identify genetic determinants 
involved in polymicrobial interactions of C. albicans with bacteria and how they control 
morphogenesis of C. albicans.  We identified 132 different genetic elements that appear 
to be involved in the ability of C. albicans to filament in the presence of three different 
bacteria (E. coli, P. aeruginosa, S. aureus).  The results from this screen begin to offer a 
better understanding of the genetics behind Candida-bacterial interactions as well as 
factors influencing the morphogenesis of C. albicans.   
Materials and Methods 
Strains, media, and growth condition.  C. albicans wild type SC5314 [30], was 
routinely cultured on Yeast Peptone Dextrose (YPD) medium (2% dextrose, 2% 
peptone, 1% yeast extract, 2% bacto agar) at 30°C.  The CDR4 deletion strains 
[SFLUC6 (cdr4/CDR4) and SFLUC4 (cdr4/cdr4] have been previously described by 
Morschhäuser et al. [31].  The ALS6 deletion strains [1522 (als6/ALS6) and 1420 
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(als6/als6)] have been previously described by Hoyer et al. [32].  E. coli 
(ATCC#33922), P. aeruginosa (ATCC#27853), and S. aureus (ATCC#25923) strains 
were maintained on Luria Broth (LB) medium (1% tryptone, 1% NaCl, 5% yeast extract, 
2% bacto agar) at 37°C. 
Screen for filamentation mutants.  A transposon insertion library of 18,144 C. 
albicans strains was constructed using C. albicans strain CAI4 [33] and a Tn7 plasmid 
insertion library created by Uhl et al [34].  To perform the screen for filamentation, the 
library strains were individually spot replicated, with two centimeter spacing, onto YPD, 
Medium 199 (M199) (9.5g medium 199 with Earles salts, 18.7g Tris-HCl, 20g bacto 
agar, pH 7.5), or M199 plates that had been pre-coated with bacterial lawns from fresh 
37°C overnight cultures.  The YPD plate was incubated at 30°C for 48 hours and served 
as a positive control for growth and a negative control for filamentation.  The M199 
control and bacterial plates were incubated at 37°C and were monitored for 
filamentation for up to seven days.  The M199 control plate (without bacteria) served as 
a positive control for filamentation.  Library candidates that filamented in the presence of 
bacteria were compared to the wild type control (SC5314) and retested twice under the 
same conditions to confirm the filamentous phenotype. 
Filamentation in liquid media.  C. albicans strains were grown overnight at 30°C, 
washed three times with dH2O and cells counted with a hemocytometer.  1x10
6 cells/mL 
were inoculated into pre-warmed medium 199 pH7.5 (37°C, control) or medium 199 
pH7.5 containing bacteria that were pre-grown overnight at 37°C.  This provided a high 
concentration of bacteria to simulate crowding conditions for C. albicans.  For spent 
media the bacteria were spun out by centrifugation 5 min at 8,000 x g, then the medium 
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was filtered to ensure removal of any remaining bacterial cells.  The spent media was 
then inoculated with the C. albicans strains. The Candida strains were incubated for 2.5 
hr at 37°C and morphology was assessed microscopically. 
Mapping of transposon insertion sites.  C. albicans library candidates that filamented 
in the presence of all three bacteria were inoculated into 5mL of YPD and incubated 
overnight at 30°C with shaking (155rpm).  Cells were harvested by centrifugation and 
chromosomal DNA was obtained using a standard bead extraction [35].  Chromosomal 
DNA was digested with BsrgI (New England), diluted 1:100, and treated with T4 DNA 
ligase (New England) to allow for the reconstitution of the original insertion plasmid.  
The ligated DNA was then transformed into E. coli TB-1 cells that were made competent 
with calcium chloride [36].  The transformed cells were plated onto LB agar plates with 
50 µg/mL ampicillin and incubated overnight at 37°C.  The successfully transformed 
cells were then grown overnight in 5 mL of LB with 50 μg/mL ampicillin and plasmid 
DNA was purified using the Promega Wizard© Plus DNA purification system.  Purified 
plasmids were sequenced using primers MKOL544: 5’-
GATCTGAGTGAGCATCAACAG-3’ or MKOL525 5’- 
GCTATGACCATGATTACGCCAGG-3’ that recognize the 5’ and 3’ flanking sequences 
of the transposon allowing for sequencing on either side of the insertion point.  The 
resulting DNA sequences were used to search the Candida Genome Database by 
BLAST comparison to identify the region of transposon insertion [37]. 
Reverse transcription and gene expression.  C. albicans SC5314, E. coli, P. 
aeruginosa, and S. aureus strains were grown in 50 mLs of YPD at either 30°C or 37°C 
until they reached mid-log phase.  Cells were then harvested by centrifugation, washed 
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with 1X PBS, and resuspended in 50 mLs of M199.  C. albicans SC5314 and single 
species bacteria were then combined in equal amounts and incubated (at 30°C or 37°C) 
with shaking (155rpms).  Aliquots were taken at 0, 10, 20, 30, 60 minutes post addition, 
cells were harvested, and samples were frozen.  Acid phenol RNA extraction was 
performed on the samples to extract total RNA [35].  Reverse transcription PCR was 
performed using a Verso 1-Step RT-PCR kit (Thermo-Fisher). Primers MKOL597 5’-
GGCAGATGCC GATACGAGTTCAAATTCG-3’ and MKOL598 5’- 
CATCAGAAGCCGAACC ATAAGCACGC-3’ were used for CDR4 RNA detection.  The 
ENO1 gene served as a loading control using primers MKOL188 5’ –
CGACTCCAGAGGTAACCC- 3’ and MKOL189 5’ – CCCAAGCATCCCAGTC – 3’. 
Primers for ALS6 detection were used as described by Zhao et al [38].  Images were 
captured using a Syngene G:Box system and analysis was performed using Gene Tools 
software by SynGene.  The experiments were performed three times; the data were 
quantified and statistically analyzed by a student’s t-test.  P-values were calculated and 
those that were significant (P<0.05) were noted. 
Results  
Identification of 295 C. albicans mutant strains that filament in the presence of 
three bacterial species.  To identify the genetic elements involved in C. albicans 
polymicrobial interactions, we utilized a C. albicans transposon insertion mutant library 
previously described by Uhl et al [34].  The library was spot replicated, along with a wild-
type (SC5314) control onto agar plates of YPD, M199, and M199 containing a lawn of 
either E. coli, P. aeruginosa or S. aureus.  To control for hyperfilamentous mutants and 
remove them from the screen, strains were grown on YPD at 30°C while mutants that 
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did not filament were screened out on M199 at 37°C.  We chose the test conditions of 
growing the strains on freshly spread bacterial lawns as this would result in a 
competitive growth condition for the Candida strains in the presence of bacteria.  Our 
choice of the Gram positive, S. aureus, and the two Gram negative, E. coil and P. 
aeruginosa, was due to their association with host environments that C. albicans is 
often known to colonize.  We scored the strains to determine if the C. albicans mutants 
filamented in the presence of one, two or all three bacterial species.  Overall we 
identified 836 strains (4.60% of the entire mutant population) that filamented in the 
presence of one or more of the bacteria.  The systematic screening of the transposon 
insertion library identified 295 individual strains that produced a filamentous phenotype 
in the presence of all three bacterial species.  We also identified 271 strains that 
filamented in the presence of two of the three bacterial species and 270 that only 
filamented in the presence of one species of bacteria.  We decided to focus our efforts 
on the mutants that filamented in the presence of all three bacterial species as these 
mutants would likely be linked to a common mechanism for C.albicans to respond to 
different species of bacteria.  Figure 2.1 depicts representative phenotypes of both the 
wild-type control as well as a C. albicans transposon library strains that produced 
filaments in the presence of bacteria.  On YPD at 30°C, the SC5314 control shows a 
colony’s typical yeast, non-filamentous, morphology with characteristic smooth rounded 
edges (Figure 2.1 A, D) while its growth on M199 without bacteria at 37°C shows 
hyphal filaments protruding from the colony (Figure 2.1 B, E).  SC5314 grown in the 
presence of high concentrations of bacteria lack filaments around the colony (Figure 
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2.1 C, F) while the mutants identified by our screen exhibit filamentation in the presence 
of all three bacterial species (Figure 2.1 G-I). 
 
Figure 2.1 Representative colony morphologies. (A) SC5314 wild-type non-
filamentous  growth on YPD agar (30°C); (B) SC5314 wild-type filamentation on  M199 
agar (37°C); (C) SC5314 wild-type filamentation inhibition in the presence of P. 
aeruginosa on  M199 agar (37°C); (D) 4X magnification of A; (E) 4X magnification of B; 
(F) 4X magnification of C; (G), (H), (I) Representative examples of library mutant 
filamentation in the presence of bacteria due to haploinsufficiency on  M199 agar (37°C) 
(4X magnification) 
Localization of the Tn7 transposon insertions.  To identify the region of genome that 
the transposon insertion was located, the recovered insertion plasmid constructs were 
sequenced and the resulting sequences were then mapped by BLAST search of the 
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Candida Genome Database (CGD) [37].  The 295 library candidates were mapped to 
132 points of insertion within genes and other genetic components of the Candida 
genome, multiple independent candidates were shown to map to the same gene further 
validating the genetic screen.  Fifty percent of the Tn7 insertions mapped within an open 
reading frame (ORF) while 18% of the insertions mapped to the 5’ upstream region and 
13% to the 3’ downstream of an ORF (Supplementary Table 2.1).  This accounted for 
107 known/predicted genes that fell into an array of categories related to gene function 
including enzymatic activity, transport, transcription, signaling, and adhesion (Table 
2.1).  By far, the majority of identified genes and ORFs fell into the category of unknown 
function.  From our screen we noted that the majority of the candidates we identified 
had not been previously associated with filamentation in general.  However the SSU1, 
FGR10, FGR24, RAS2, MRP2, and CCR4 haploinsufficient mutants we identified in our 
screen also overlap with the dataset from a haploinsufficient library screen performed by 
Uhl et al. [34] for filamentous mutants.  In their study, Uhl et al [34] screened for 
hyperfilamentous and less filamentous mutants using different conditions than we 
utilized in this study.  These mutants did not show any hyperfilamentous or less 
filamentous phenotypes under our control conditions indicating variability between the 
two experimental approaches.  
A number of insertions (5%) were mapped to the RPS and RB2 repeat regions 
located within the major repeat sequences (MRS) of MRS-1, -2,-4,-6, -7a, -7b, and –R 
units (Supplementary Table 2.2).  There were no Tn7 insertions found within MRS-5, 
nor the partial RB-2-4a repeat unit.  Within the RB2 repeat region, Uhl et al previously 
identified a family of genes, FGR6, which have no clearly defined function other than 
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their association with fungal growth [34].  It appears that at least seven of eight FGR6 
family members (FGR6-1, FGR6-3, FGR6-4, FGR6-10, orf19.727, orf19.6896, 
orf19.5775) are involved in regulating filamentous growth in the presence of bacteria. 
Finally, 14% of the insertions were mapped to non-coding transcripts or unannotated 
ORFs (Supplementary Table 2.3).  Many of these transcripts were characterized 
previously by RNA-seq analysis [39] and tiling arrays [40], but have not been further 
characterized regarding their functional roles in the cell.  We use the term “transcripts” 
at this time as the transcribed regions have not been designated officially as protein 
coding ORFs or regulatory RNA genes in the CGD. 
Table 2.1.  Biological process categories of genes identified from library screen 
  
Biological Process Gene/orf identified 
Enzymatic activity ALK8, FMO1, GCA2, GOR1, GCV1, IAH1, PLC1, orf19.346, orf19.511, orf19.1110,  
 orf19.2114, orf19.4112, orf19.4246, orf19.5169, orf19.5665, orf19.7152 
 orf19.7512 
Adhesion ALS6, EAP1, PGA28, orf19.5813  
Cell wall associated BMT8, GSC1, GSL1, PGA52 
Cell cycle IRR1, MAD2, NUF2, TEM1 
Signal transduction CAS4, RAS2, TOR1 
Transport CDR4, CRM1, GNP3, MGE1, POM152, RTA3, SSU1, orf19.6592, orf19.6747 
Transcription BDF1, CCR4, CTA24, CRZ2, HAP31, PHO23, SPT7, SUA72, ZCF11, orf19.536  
 orf19.470 
Translation MRP2, TIF5, orf19.4176 
Protein processing DNM1, orf19.3730, orf19.3767, orf19.4086, orf19.5212, orf19.6082,  
 orf19.7358 
Proteolysis AXL1, FGR10, orf19.4610 
RNA processing ILS1, NHP2, POP3, SEN1, orf19.1201, orf19.6736, orf19.6931 
RNA binding orf19.3124, orf19.4018 
DNA binding orf19.2579, orf19.7301 
DNA repair MEC3, SMC5, orf19.4412, orf19.6722, MMS21 
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Ribosomal 
associated 
SOF1,RPS12, RPS18  
Amino acid 
synthesis 
CHA1, ECM17, HPA2 
Autophagy SPO72, orf19.2982 
Unknown 
FGR34,orf19.344, orf19.1368, orf19.1728, orf19.2038, orf19.2106, 
orf19.3087.2, 
 orf19.3100, orf19.3394, orf19.3643, orf19.4263, orf19.5799, orf19.5897 
 orf19.6488, orf19.6968, orf19.7085, orf19.7130, orf19.7567 
 
Confirmation of phenotypes for cdr4/CDR4 and als6/ALS6 haploinsufficient 
mutants.  Although we identified independent insertions near or within the same gene 
multiple times from this screen, to further confirm our observed phenotypes we chose 
two mutants, als6/ALS6 and cdr4/CDR4, to be tested using independently 
constructed heterozygous and homozygous null strains.  The ALS6 mutant was chosen 
as the original Tn7 library insertion point was in the promoter region of this gene, while 
the CDR4 mutant was chosen as the insertion fell within the open reading frame.  The 
als6 and cdr4 heterozygous and homozygous null strains (obtained from Drs. Hoyer and 
Morschhäuser) were spot replicated with our haploinsufficient als6/ALS6 and 
cdr4/CDR4 library strains onto YPD, M199, and M199/bacterial plates using the same 
conditions from the original library screen.  The phenotypes of the als6 and cdr4 
heterozygous and homozygous null strains were similar if not identical to those we saw 
with our Tn7 mutant isolates (Figure 2.2), thereby confirming our original observations 
and the validity of using haploinsufficiency for characterizing bacterial-Candida 
interactions.  Furthermore, we examined the morphology of the strains in liquid culture 
in the presence of bacteria and spent media (Supplementary Figure 2.1).  When cells 
were cultivated under hyphal inducing conditions in M199 we observed all strains 
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exhibiting a hyphal morphology, whereas the control strain showed clear impairment of 
filamentation when grown in the presence of all three bacterial species.  All the mutant 
strains filamented in the presence of all three bacterial species with hyphae being the 
predominant morphology (Supplementray Figure 2.1A).  Also when C. albicans was 
inoculated into spent media that the bacteria had been removed from the mutants were 
capable of filamenting as hyphae and the wild type strain was impaired as mainly yeast 
and some pseudohyphae (Supplementary Figure 2.1B).  This result also suggests that 
primary mediator(s) inhibiting C. albicans filamentation are secreted actively by the 
bacteria. 
 
Figure 2.2   Representative photos of observed phenotypes of SC5314, library 
transposon candidates, and cdr4 and als6 heterozygous and homozygous 
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deletion strains. YPD growth control (30°C), 40x magnification;  M199 filamentation 
control (37°C), 100x magnification; E. coli interactions with C.albicans strains, 100x 
magnification; P. aeruginosa interactions with C. albicans strains, 100x magnification; S. 
aureus interactions with C. albicans strains, 100x magnification. 
 
C. albicans CDR4 expression increases in the presence of S. aureus.  C. albicans 
and the individual bacterial strains were co-cultured and CDR4 transcript levels were 
analyzed over time.  The SC5314 cells co-incubated with S. aureus at 37°C exhibited 
over a two-fold increase in CDR4 expression over the time course of 60 minutes as 
compared to the SC5314 control without bacteria (Figure 2.3 and Supplementary 
Figure 2.2).  There was little to no change in CDR4 expression in the presence of E. 
coli or P. aeruginosa, nor was there any change in CDR4 expression when tested at 
30°C with any of the three bacterial species (data not shown). We also observed that 
spent bacterial culture media (bacteria removed by filtration) was unable to stimulate the 
expression of CDR4 (data not shown).  This suggests that a combination of physiologic 
temperature and (in the case of S. aureus) some sort of contact between the organisms 
is required for CDR4 induction.  Others have shown that changes in morphology and 
growth may require live bacteria to be present in the media to have a full inhibitory effect 
on Candida filamentation [13].  This would suggest that C. albicans interactions with 
bacteria are multifactorial encompassing both contact dependent mechanisms as well 
as secreted molecular factors.  We also examined the expression of ALS6, however no 
increase in transcript level was observed with any of the growth conditions (data not 
shown). 
63 
 
 
Figure 2.3 C. albicans CDR4 transcript levels grown in the presence of bacteria.  
C. albicans SC5314, E. coli, P. aeruginosa, and S. aureus were grown to mid log phase 
in liquid culture, mixed together in equal amounts, co-incubated at 37°C, and aliquots 
were taken at 0, 10, 20, 30, and 60 minutes post addition.  RNA was isolated and 
expression of CDR4 was measured by reverse transcription.  ENO1 was used as a 
loading control and reference gene for expression comparisons. Graphical 
representation of CDR4 expression over time for SC5314 co-incubated with E. coli, P. 
aeruginosa, or S. aureus.  Data is representative of three independent experiments with 
mean value and standard deviation bars shown.  The asterisks indicate a statistically 
significant difference (P<0.05) in mean intensity of test conditions over the control. 
 
Discussion 
The microbiome of the human body plays an important role in our health.  Currently, 
studies involving the microbiota have only examined what the microbial population 
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structures appear to be in both healthy and diseased individuals [41–43].  Because the 
opportunistic fungus C. albicans is a member of normal flora, it is thought that C. 
albicans growth is held in control by other microorganisms as well as the hosts’ immune 
system.  Patients that are immunocompromised or those being treated with broad 
spectrum antibiotics can create an environment allowing C. albicans the opportunity to 
expand its growth due to the reduction of factors secreted by other organisms that 
would normally suppress filamentous growth.  In order to understand how both Gram 
positive and Gram negative bacteria impair C. albicans ability to filament we performed 
a genetic screen using haploinsufficiency to identify common targets in C. albicans that 
are used by both types of bacteria to impair C. albicans growth.  Though it is an 
imperfect means to screen for all possible genes related to a particular phenotype due 
to the diploid nature of C. albicans, haploinsufficiency has been used previously to 
identify strains showing reduced or increased filamentation [34] as well as changes in 
fitness related to drug susceptibility and growth rates [44].  Using this approach we were 
successful in identifying 107 genes/ORFs that likely play some role in C. albicans 
filamentation response in the presence of various bacterial species. 
The genes identified from this screen fell into a variety of biological functions 
including adhesion, cell cycle, enzymatic activity, signaling, transcription, and transport. 
For example, the identification of several genes involved in various types of transport 
was quite surprising.  Several of the genes we identified were associated with the 
plasma membrane (CDR4, RTA3, and GNP3) while others were associated with 
nuclear (CRM1, POM152) or mitochondrial (MGE1, SSU1, orf19.7358) transport.  The 
transporters associated with the plasma membrane likely are used by C. albicans for 
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import/export of bacterial metabolites and QS molecules from the surrounding 
environment.  We speculate that mutations in the CRM1 or POM152 genes may be 
interfering with export/import of signaling proteins or transcriptional regulators required 
to respond to the presence of bacteria in the environment.  It is quite possible that 
MGE1, SSU1, or orf19.7358 transporters may be involved in transporting bacterial 
molecules that interfere with several other genes associated with mitochondrial function 
(DNM1, GCU1, MRP2, orf19.346, orf19.1201, orf19.4176, orf194018, orf19.4472, and 
orf19.7152), as mutants of these genes were also shown to be impaired in the 
filamentation response to all three bacteria.  The cdr4, rta3 and gnp3 mutants are 
interesting in that Rta3p is a predicted flippase, which may participate in lipid molecule 
translocation across the membrane.  Likewise the Gnp3p is predicted to be a high 
affinity glutamine transporter which could serve as a point for small peptide transport. 
Additionally, Cdr4p has no characterized functional role even though it is a member of a 
family of ABC transporters, Cdr1-3p [45,46].  Cdr1p and Cdr2p are important in C. 
albicans drug resistance [46,47], while Cdr3p is involved in import of phospholipids [45]. 
It is possible that Cdr4p plays a role in the import of small peptides or other molecules 
as ABC transporters have been implicated in peptide transport in S. aureus as well as 
autoinducer-2 transport in E. coli [48,49].  We did observe that heterozygous and 
homozygous mutants of CDR4 display identical phenotypes to that of our original library 
isolate, further implicating its role in C. albicans interaction with bacteria.  Surprisingly, 
CDR4 expression was only induced when S. aureus was present in the environment 
with C. albicans.  S. aureus, along with several other Gram positive bacteria, is known 
to produce small peptide QS molecules.  It may be that close contact with C. albicans 
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results in the liberation of these molecules from S. aureus and C. albicans increases its 
expression of CDR4 in response to these peptides.  This may also be specific to Gram 
positive bacteria, for example, when C. albicans is co-cultured with Lactobacillus 
rhamnosus or Lactobacillus reuteri there is a two to three fold increase in CDR4 
expression [50], Since we did not observe any major change in CDR4 expression when 
C. albicans was grown with E. coli or P. aeruginosa, may indicate that these organisms 
don’t produce a peptide required for CDR4 induction.  The fact that mutants lacking 
CDR4 or have reduced expression of the protein may indicate that Cdr4p is playing a 
role as an importer of bacterial peptides and other molecules as well as C. albicans 
inability to block filamentation in response to the presence of bacteria is a direct result of 
Cdr4p’s absence. 
A second categorical group identified from the screen is the four genes (ALS6, 
EAP1, PGA28, and orf19.5813) that are associated with adhesion.  Previous work had 
found that the attachment of C. albicans to S. gordonii involves multiple interactions 
between several components of the bacterial cell wall and C. albicans components [51].  
Recently, it had been shown the EAP1 and ALS3 genes, when expressed in S. 
cerevisiae, conferred the ability of S. gordonii to attach to S. cerevisiae [52].  The ALS3  
gene has also been shown to be involved in mediating aggregation and, more 
specifically, directing the attachment of S. aureus to the hyphal form of C. albicans [53].  
The identification of the eap1 mutant in our screen may indicate that the protein plays 
not only a role in adherence to bacterial surfaces but may somehow be linked to C. 
albicans ability to “sense” other organisms in its environment.  ALS6 belongs to the ALS 
family of adhesins involved in attachment to biotic and abiotic surfaces, biofilm 
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formation, and virulence, however the specific role of ALS6 is unknown at this time [52–
54].  Though we did not identify an als3 mutant, the identification of only als6 in our 
screen may also signify some importance with regards to attachment and “sensing” of 
bacteria in the environment.  It is possible that other members of the ALS gene family 
could play some role in attachment and “sensing” of bacteria in the environment but due 
to the nature of this screen, the reduction in gene expression of one copy of other ALS 
genes may be insufficient to create a haploinsufficient phenotype.  To our knowledge, 
no implication of the ALS gene family in signal transduction has been suggested in the 
literature.  The ability of these proteins to “sense” bacteria would also add a new 
functional role for these adhesion proteins with a relation to signal transduction.  As with 
CDR4 we did confirm our original screen results with heterozygous and homozygous 
null mutants of ALS6 further lending credibility to its involvement in Candida-bacterial 
interactions.  However unlike CDR4 we did not see any induction of ALS6 in the 
presence of the bacteria.  Regardless, it is clear that ALS6 plays some role in either the 
adherence to bacteria or “sensing” bacteria in the environment and is somehow able to 
convey that response by inhibiting Candida filamentation. 
We were quite surprised to identify multiple insertions within the RPS and RB2 
regions of the MRS.  In the original use of the haploinsufficiency screen by Uhl et al 
[34], they also identified insertions within these regions from four clones that either 
increased or decreased filamentation under their experimental conditions.  They 
identified one ORF they termed FGR6 (fungal growth regulator) within the RB2 region, 
though as to its actual function nothing is currently known.  There are eight copies of 
this gene in the genome that all reside within the RB2 region of the MRS elements 
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[37,55].  It has been suggested that mutations affecting the FGR6 family of genes 
phenotypically are not believed to be due to haploinsufficiency but some type of 
dominant regulatory mechanism [55].  Though we have no evidence, it is also possible 
that insertions of the Tn7 elements into the MRS regions could locally destabilize a 
region of a chromosome, inadvertently causing a chromosomal 
translocation/rearrangement thereby affecting the observed phenotype in this screen.  
The identification of 18 non-coding/unannotated transcripts also was unexpected.  
These transcripts were previously identified using RNA-seq and gene tiling studies on 
the C. albicans genome [39,40].  These non-coding or unannotated transcripts may 
represent small protein coding genes with fewer than 90 amino acids or could possibly 
be new types of regulatory RNAs that may represent an additional level of control on the 
morphogenic process.  Currently, little to nothing is known about the role of non-coding 
transcripts or small ORFs below 90 amino acids and their role in C. albicans 
morphogenesis.  However, the idea that several of these transcripts could code for 
regulatory RNAs is intriguing.  None of the transcripts appear to be transcribed as 
antisense with other known ORFs so it is possible that they could play a role in RNA 
silencing.  Nevertheless, there has been some controversy about whether RNA 
silencing actually occurs in C. albicans.  Initially, using cell extracts, it had been shown 
that C. albicans does have a Dicer-like activity [56].  A second study demonstrated that 
in vivo production of a dsRNA hairpin to interfere with the ADE2 gene resulted in no 
observable gene silencing [57].  Furthermore, characterization of the DCR1 dicer gene 
of C. albicans demonstrated that this activity is primarily associated with rRNA and and 
snRNA processing [58].  So, it appears that if the transcripts we have reported here 
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have any impact on RNA silencing of RNA pol II transcribed genes the mechanism is 
likely unknown or does not exist in C. albicans. 
This study has allowed us to develop the framework for future delineation of the 
genetic and signaling events that occurs between Candida and bacteria.  We postulate 
that this genetic overlap with response to different bacterial species involves several 
common pathways that C. albicans utilizes for communication.  However, several 
questions remain.  For example, do the mutants we identified show a lack of response 
to bacteria in their environment due to a single secreted bacterial metabolite or QS 
molecule, or is it a combination of several molecules that exert the inhibitory action on 
C. albicans?  It is well documented that single molecules from bacteria can inhibit C. 
albicans filamentation under laboratory conditions [11,12,14,16,17], but it is not well 
understood if these molecules are present in the environment at all times, which could 
indicate a combination of effectors may be required in the environment.  Also, do the 
mutants that we have identified in this study also play a role in C. albicans QS 
regulation of filamentation or is that a separate phenomenon?  We believe that it is likely 
that C. albicans uses some of these genes to regulate its own QS response as it doesn’t 
make sense that C. albicans would have developed separate molecular machinery to 
respond to both types of stimuli.  We hope to address these questions in future studies. 
We believe that in understanding the mechanisms of action of both bacterial QSMs and 
other metabolites on C. albicans biology may lead to development of novel ways to 
control C. albicans growth in critically ill patients in addition to current antifungal 
therapies.  
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Abstract 
Numerous organisms inhabit the human body living out a life of intimate relationships 
and unique interactions.  Among these interactions are those involving the opportunistic 
polymorphic fungi, Candida albicans, with bacteria.  The ability of C. albicans to control 
morphology, communicate via quorum sensing, attach to numerous surfaces, and form 
complex biofilms are all important virulence factors of this fungal pathogen.  Research 
within the last decade has highlighted numerous bacterially secreted molecules that can 
influence the dimorphic transition of C. albicans, yet little is known about how these 
interactions function at a genetic level.  In the present study, we characterized the 
involvement of two genes, CDR4 and ALS6, previously identified by our lab for their 
involvement in Candida-bacterial interactions.  Strains lacking either CDR4 or ALS6 
have increased filamentation as compared to wild-type strains when grown in the 
presence of the C. albicans quorum sensing molecule farnesol as well as several 
bacterial molecules known to inhibit filamentation.  CDR4 and ALS6 null strains have 
increased adhesion and biofilm growth when grown in the presence of farnesol and 
bacterial molecules.  Our data indicates that both CDR4 and ALS6 are part of the 
machinery that defines how C. albicans responds to not only its own quorum sensing 
molecule, but also bacterial products it can encounter in the environment.  Delineating 
the roles of CDR4 and ALS6 regarding Candida-bacteria interactions may aid in the 
understanding of polymicrobial infections as well as identify new targets for antifungal 
development. 
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Introduction  
With the recent findings of the Human Microbiome Project the impact microorganisms 
have on human health is only beginning to be appreciated.  For the first time, we now 
have a snapshot of what constitutes a “healthy” individual.  However, little is understood 
about how members of the human microbiota interact and govern their behavior within 
and on the host [1-5].  With the number of microorganisms constituting the microbiome 
in the trillions there undoubtedly are a multitude of interactions, influences, and 
competitiveness for a small amount of space and resources.  This includes the 
interactions between bacteria and the polymorphic opportunistic fungus Candida 
albicans.  Indeed, C. albicans is part of the normal flora for about 75% of the human 
population and is particularly dangerous when it transitions from a member of the 
normal flora to an opportunistic pathogen [6].  Among the populations that are at 
increased risk for C. albicans infections are those of extreme age (both the young and 
the elderly), immune suppressed, patients undergoing cancer treatment, and those on 
long term antibiotic use [7,8].  In the hospital setting, C. albicans is quickly emerging as 
an important healthcare concern as it is the most common fungal pathogen, the fourth 
most common pathogen in systemic infections, and exhibits an increase in resistance to 
current antifungal treatments [9-11].  
 A distinguishing virulence factor of C. albicans is its unique ability to control 
morphology ranging from budding yeast to pseudohyphae to invasive hyphal filaments.  
While the yeast form governs attachment and dissemination, it is the hyphal form that is 
associated with severe infections [12,13].  Morphological control is mediated in C. 
albicans through quorum sensing (QS) by the quorum sensing molecule (QSM) 
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farnesol, an isoprenoid alcohol [14].  This phenomenon works in a density dependent 
manner and allows C. albicans to coordinate morphology in response to the surrounding 
environment.  In addition to QS, filamentation can be manipulated in C. albicans by a 
number of physiological factors such as pH, temperature, media, nutrients, or serum 
[15,16].  The ability of C. albicans to control morphology is imperative for survival, 
particularly in the human body where it is constantly in competition with bacteria for 
space and resources as well as fending off host immune responses.  
  Numerous physical and chemical interactions have been identified between C. 
albicans and bacteria.  Perhaps the most studied of the physical interactions is that of 
Pseudomonas aeruginosa and C. albicans and the antagonistic relationship they share.  
P. aeruginosa can bind to and kill the hyphal-filamentous form of C. albicans, but not the 
yeast form [17].  Alternatively, Streptococcus gordonii and Staphylococcus epidermidis 
appear to have the ability to attach to both the yeast and hyphal forms of C. albicans 
[18,19].  More recently, research has focused on small molecules secreted by bacteria 
that impact C. albicans morphology.  Specific molecules or spent media from a variety 
of bacteria including Lactobacillus, Streptococcus, Pseudomonas, and Burkholderia 
have been shown to interrupt C. albicans ability to transition between morphological 
forms and many times these small bacterial molecules cause C. albicans to become 
locked into the yeast form [1,20-22].  Alternatively, S. gordonii, and bacterially derived 
molecules, such as peptidoglycan, appear to enhance hyphal formation in C. albicans 
[18,23].  These analogous and conflicting effects that bacteria exert on C. albicans 
demonstrate the dynamic relationships involved in a shared environment in an attempt 
to achieve a competitive advantage.  
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Previously, our lab performed a large scale library screen to identify genes that 
C. albicans utilizes to control filamentation in the presence of bacteria [24].  Two of 
these genes, ALS6 and CDR4, have shown potential to play participating roles in this 
process.  In this study, we demonstrate the involvement of ALS6 and CDR4 in C. 
albicans response to farnesol as well as bacterial molecules as it pertains to 
morphogenesis, attachment, biofilm formation, and gene expression.   
Methods 
Strains, media, and growth condition.  C. albicans strains were routinely cultured on 
Yeast Peptone Dextrose (YPD) medium (20g dextrose, 20g peptone, 10g yeast extract, 
20g bacto agar in 1 liter) at 30°C.  C. albicans wild-type SC5314 [25], CDR4 deletion 
strain (cdr4/cdr4) [26], and ALS6 deletion strain (als6/als6) [27] have previously 
been described.  In all subsequent experiments, C. albicans strains were inoculated into 
YPD and grown overnight for 16 hours at 30°C with shaking (155 rpm).  Cells were 
harvested by centrifugation, washed twice with sterile ultrapure water, and inoculated 
into Medium 199 (M199) (9.5g medium 199 with Earles salts, 18.7 Tris-HCl, 20g bacto 
agar, pH 7.5 ,q.s. to 1L).   
Liquid filamentation assay.  Filamentation assays were performed as previously 
described, but with minor alterations [28].  Briefly, prior to cell addition, trans,trans-
farnesol (Sigma), trans-2-decenoic acid (TCI America), indole (Sigma), N-3-oxo-
dodecanoyl-L-homoserine lactone (HSL) (Cayman), lipopolysaccharide (LPS) from E. 
coli (Sigma), Competence Stimulating Peptide-1 (CSP1) from Streptococcus mitis  
(Genscript), 1-dodecanol (Acros), phenazine (Acros), and pyocyanin (Cayman) were 
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added to pre-warmed (37°C) M199 liquid media.  Washed C. albicans cells were 
inoculated (1 x 106 cells/mL) and incubated under hyphal inducing conditions (M199, 
pH7.5, 37°C, 155 rpm) for two and a half hours.  Aliquots were then examined 
microscopically (400x) for cell morphology.  For each experimental condition 300 
cells/field were counted and results were reported as the average of triplicate 
experiments in terms of the percent of total cells displaying hyphal morphology.   
Cell attachment assay.  The cell attachment assay was performed as previously 
described with some modifications [29].  Briefly, 96 well plates were pre-coated with 5% 
serum and incubated overnight at 4°C.  Excess serum was then removed from the wells 
and trans,trans-farnesol, trans-2-decenoic acid, indole, HSL, or LPS were diluted into 
either methanol, water, or DMSO and added to pre-warmed (37°C) M199 media at 
varying concentrations in the 96 well plates.  Cells were inoculated at 1 x 105 cells/well 
and plates were incubated at 37°C for 90 minutes to allow for attachment.  Plates were 
then washed with sterile dH2O, to remove non-bound cells.  They were air dried, stained 
with 100μL crystal violet, washed with dH2O after 10 minutes, treated with 033% acetic 
acid to release the stain and transferred to a second plate where the absorbance 
(600nm) was measured using a Turner Biosystems modulus microplate reader.  
Attachment assays were carried out in three independent trials with each individual trial 
carried out in triplicate. 
Biofilm assay.  The biofilm assay was carried out similarly to the attachment assay with 
minor modifications [29].  Again, 96 well plates were pre-coated with 5% serum and 
incubated overnight at 4°C.  Excess serum was removed from the wells and strains 
were inoculated (1x106 cells/mL) into pre-warmed M199 media, added to each well, and 
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incubated at 37°C for 90 minutes to allow for attachment.  The attached cells were then 
washed to remove non-bound cells and fresh media containing trans,trans-farnesol, 
trans-2-decenoic acid, indole, HSL, or LPS were added and the plates were incubated 
for 48 hours at 37°C.  Plates were then assayed as described above [30].  Biofilm 
assays were carried out in three independent trials with each individual trial carried out 
in triplicate. 
Results and Discussion  
In this study, we chose to examine two genes previously identified by our lab for their 
role in Candida-bacterial interactions regarding the C. albicans virulence traits of 
filamentation, attachment, and biofilm formation.  The first gene, ALS6, belongs to a 
family of cell surface glycoproteins that are associated with adhesion to surfaces [31].  
The ALS1 and ALS3 family members have also been demonstrated to be involved in 
Candida-bacterial interactions by mediating aggregation [32] and particularly in the 
adherence of C. albicans to Staphylococcus aureus [33].  Deletion of ALS6 has been 
shown to cause an increase in adhesion to human cells [27] so there is some question 
as to the specific role of ALS6.  This increase in adhesion by the als6-/- strain may 
indicate that there is some sort of coordinated regulation within the ALS gene family for 
adherence.  It is entirely possible that since ALS6 is not a highly expressed protein it 
may play a specialized role in the ALS gene family, possibly it functions to “see” and 
“sense” the environment for contacts with bacterial and host cells rather than a direct 
role in adherence.  The second gene we examined, CDR4, belongs to a family of ABC 
transporters [26].  While CDR1 and CDR2 are involved with C. albicans resistance to 
fluconazole and transport of phospholipids [34], CDR4 does not appear to play a role in 
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fluconazole resistance and the cellular function of CDR4 is unknown at this time [26].  In 
regards to CDR4 involvement in polymicrobial interactions, co-cultures of Lactobacillus 
rhamnosus or L. reuteri [35] with C. albicans causes a 2 to 3 fold increase in CDR4 
expression.   As these are Gram positive bacteria that produce peptide QSMs it is 
possible that CDR4 induction is in relation to uptake of these peptide molecules.  S. 
aureus has been shown to regulate its QS response in a similar fashion using ABC 
transporters in the import of secreted peptides [36], however, ABC transporters are 
known to import and export a large variety of compounds into and out of the cell [37].  
C. albicans cdr4-/- and als6-/- strains have increased filamentation in the 
presence of farnesol and several bacterial molecules.  We have previously identified 
mutants of CDR4 and ALS6 that were able to filament in the presence of high levels of 
bacteria. To determine the involvement of CDR4 and ALS6 in the response to farnesol, 
bacterial QSMs, and other bacterial metabolites, SC5314 wild type and null strains were 
grown in the presence of a panel of molecules known to affect morphogenesis.   
SC5314, cdr4 -/-, and als6 -/- strains were grown under hyphal inducing conditions for 
2.5 hours with or without the addition of CSP1, 1-dodecanol, trans,trans-farnesol, HSL, 
indole, LPS, phenazine, pyocyanin, or trans-2-decenoic acid.  We also performed this 
assay with reconstituted heterozygous strains of CDR4 and ALS6, which exhibited 
phenotypes identical to the homozygous nulls (data not shown).  We chose these 
compounds as they are known to be secreted into the environment by bacteria, with the 
exception of farnesol, which is the QSM of C. albicans and 1-dodecanol.  Dodecanol 
has previously been used as a surrogate for HSL when inhibiting hyphal filamentation 
[38].  However, it has been demonstrated that dodecanol exerts its effect on C. albicans 
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differently than HSL [39].  We chose farnesol to determine if the mutant strains would 
respond to the QSM.  Using increasing amounts, we attempted to identify 
concentrations of the various molecules that demonstrated a measureable effect, but 
not completely inhibitory due to potential toxicity (Supplementary Figure 3.1).  Figure 
3.1A is a representation of the concentrations where a measureable effect was 
observed on the cells by the molecules, but without toxicity.  The addition of these 
molecules did not alter growth rates and the solvents (methanol, water, or DMSO) used 
to dilute the molecules had no significant effect on morphology (data not shown).  Also, 
solvents never constituted more than 1% of the total volume.  Under control conditions, 
after 2.5 hours 93% of the wild-type SC5314 strain cell population displayed the typical 
hyphal-filamentous dominant morphology while cdr4 -/- and als6 -/- strains show similar 
morphology to the wild-type SC5314 control with about 91% of cell populations 
producing hyphae.  Farnesol served as a control for filamentation with the wild-type 
strain, but also as a test for determining whether the als6-/- and cdr4-/- strains respond 
to the molecule.  The addition of farnesol at 50µM, 150µM, and 300µM concentrations 
greatly reduced wild-type SC5314 hyphal morphology populations to 32%, 15%, and 
11% respectively.  At 50µM, 150µM, and 300µM concentrations of farnesol, the cdr4-/- 
strain had 57%, 40%, and 19% hyphal morphology while als6-/- had 56%, 30%, and 
15% hyphal morphology, thus both deletion strains had significantly increased hyphal 
morphology over wild-type SC5314 (Figure 3.1A and Supplementary Figure 3.1).  
Figure 3.1B demonstrates the observed hyphal phenotypes of the cdr4-/- and als6-/- 
clearly indicating they are refractory to the molecule and are involved in C. albicans QS 
response.  The cdr4-/- and als6-/- strains were refractory to a number of bacterial 
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molecules as well.  At 50µM and 200µM concentrations of HSL, cdr4-/- had significantly 
more hyphal cells (79% and 15%) than wild type (65% and 9%) at both concentrations 
while als6-/- (14%) only displayed increased hyphae over wild-type SC5314 at the 
200μM concentration (Figure 3.1A and Supplementary Figure 3.1).  At 1mM and 
2mM concentrations of indole, cdr4-/-  (81% and 65%) and als6-/- (81% and 72%) 
strains were also able to produce more hyphae than wild-type SC5314 (72% and 56%), 
however this was not enhanced above 2mM with almost all cells in all three strains 
having yeast morphology at 4mM concentrations (Figures 3.1A and Supplementary 
Figure 3.1).  trans-2-decenoic acid required relatively small concentrations to observe 
hyphal morphology population differences.  The addition of 1µM of trans-2-decenoic 
reduced SC5314 to near 54% hyphal morphology and 5µM greatly exacerbated this 
effect to 19% hyphae.  The cdr4-/- and als6-/- strains still retained the ability to produce 
significantly more hyphal cells at 1µM, 69% and 63% respectively, and this was also 
observed at 5µM with both cdr4-/- and als6-/- at around 30% hyphae.  At 25 µM of 
trans-2-decenoic acid concentrations all three strains produced negligible amounts of 
hyphal cells (Figure 3.1A and Supplementary Figure 3.1).  LPS has also been 
demonstrated to inhibit filamentation of C. albicans. We observed that at 1ug/mL cdr4-/- 
(47%) had the most refractory phenotype while the als6-/- strain (20%), surprisingly, 
appeared to be more sensitive than the wild-type SC5314 (30%) with more yeast cell 
phenotypes (Figure 3.1A and Supplementary Figure 3.1).  Adding CSP1, phenazine, 
and pyocyanin decreased the percentage of hyphal cells, but did so at similar and 
insignificant levels when cdr4-/- and als6-/- strains were compared to wild-type SC5314, 
indicating that the activity of these molecules  is not dependent on ALS6 or CDR4.  
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Interestingly, 1-dodecanol concentrations at or above 50µM, almost completely ablated 
the ability of all three strains to produce hyphae indicating that response to dodecanol is 
not through the same mechanism, but due to some other stress on the cells (Figure 
3.1A and Supplementary Figure 3.1).   
     Of the molecules tested, the reduced response to trans,trans,-farnesol was the 
greatest when comparing cdr4-/- and als6-/- deletion strains to the wild type control.  
While the deletion strains did have fewer hyphal cells in the presence of exogenously 
added trans,trans-farnesol, they still produced twice the number of hyphal cells as the 
control.  The addition of indole, trans-2-decenoic acid or HSL reduced hyphal cell 
numbers in all strains, but the cdr4-/- and als6-/- deletion strains maintained increased 
numbers of hyphal cells.  This could indicate that there is a global signal-response 
cascade that C. albicans utilizes in the control of morphogenesis in reaction to its own 
QS molecule as well as bacterially secreted factors.  Numerous bacterial molecules that 
have been identified to inhibit C. albicans morphogenesis share similar carbon 
backbone molecular structures to farnesol.  HSL from P. aeruginosa 1 and varying forms 
of decenoic acid from S. mutans, B. cenocepacia, and X. campestris [21,22,40] all 
share structural similarities to farnesol and appear to inhibit hyphal morphogenesis.  
The fact that the deletion strains in the presence of inhibitors did not restore hyphal cell 
populations to control levels could indicate that CDR4 and ALS6 play participating or co-
factor roles in the genetic pathway regarding small molecule regulation of 
morphogenesis.  It is also possible that CDR4 and ALS6 are not critical regulators of 
this pathway and can be compensated in part by other genetic factors, but the fact that 
deletion of these factors causes a significant increase in hyphal morphology cannot be 
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disregarded.  Perhaps the most interesting result of the filamentation assay was that 
cdr4-/- and als6-/- were not responsive to farnesol and HSL, but were to dodecanol.  
Dodecanol has been used in many publications as a substitute to HSL and as a control 
in experiments as a hyphal formation inhibitor [1,38].  However, recent research has 
shown that dodecanol acts along a different mechanism than that of farnesol and HSL 
[39]. This could indicate, when evaluated with our results, that CDR4 and ALS6 act 
along a separate signaling system and accounts for the increase in hyphal morphology 
of the deletion strains to farnesol and HSL, but not dodecanol.  It is important to note, of 
the bacterial compounds tested, some did not produce significant differences between 
the control and deletion strains.  CSP1, phenazine, and pyocyanin reduced hyphal cell 
numbers equally in both the wild-type control strain as well as the cdr4 and als6 deletion 
strains. It is worth mentioning that the CSP1 used in this study is different from the 
CSP1 used in the original paper identifying these peptides as inhibitors of 
morphogenesis [41] which may explain the inability of it to elicit a reaction in the control 
and mutant strains we tested. 
Figure 3.1 (a) The effects of trans,trans-farnesol and bacterial molecules on 
morphology of C. albicans SC5314 wild-type, cdr4-/-, and als6-/- strains. Strains were 
grown under hyphal inducing conditions (pH7.5, 37°C, M199 media) for 2.5 hours with 
or without the addition of bacterial molecules: competence stimulating peptide-1 (CSP), 
1-dodecanol (DOD), trans,trans-farnesol (FRN), 3-oxo-C12-homoserine lactone (HSL), 
indole (IND), lipopolysaccharide (LPS), phenazine (PHN), pyocyanin (PYO), or trans-2-
decenoic acid (TDA).  Morphology was determined microscopically by counting 300 
cells and expressed as the percentage of cells displaying hyphal morphology.  Asterisk 
denotes statistical significance (p < 0.05) compared to matched SC5314 wild-type 
control as determined by student’s t-test.  The mean and standard deviation of triplicate 
trials are shown. (b) Effects of trans,trans-farnesol on morphology of C. albicans wild-
type, cdr4-/- and als6-/- strains. Strains were inoculated (1x106 cells/mL) into hyphal 
promoting conditions (ph7.5, 37°C, M199 media) with or without the addition of 150µM 
of trans,trans-farnesol.  After 2.5 hours morphology was examined.  (Top panel) wild-
type SC5314 control, (Middle panel) cdr4-/- deletion strain, (Lower panel) als6-/- 
deletion strain. 
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C. albicans cdr4-/- and als6-/- cells have increased attachment and biofilm 
formation in the presence of farnesol and known bacterial inhibitors. Farnesol has 
been known to inhibit or reduce the ability of C. albicans to adhere to abiotic surfaces 
[42].  Taking the molecules that were found to be significant in the filamentation assay, 
the next step was to measure the ability of C. albicans to adhere to polystyrene surface 
in the presence of trans,trans-farnesol, indole, trans-2-decenoic acid, HSL, or LPS.  C. 
albicans SC5314, cdr4-/-, and als6-/- strains were inoculated into M199 with the addition 
of farnesol or bacterial molecules and incubated under hyphal inducing conditions for 
1.5 hours to allow for attachment.  The effects of increasing concentrations of these 
molecules on C. albicans wild type and null strains in regards to attachment are shown 
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in Figure 3.2 and Supplementary Figure 3.2.  Since values were obtained in respect 
to optical density the untreated SC5314 control was designated as 100% attachment 
and all other percent values were determined in relation to this optical density value.   
SC5314, cdr4-/-, and als6-/- strains, without added molecules, served as a control 
baseline and all three strains had near equal ability to attach to the 96 well plates.  The 
addition of trans,trans-farnesol reduced the attachment ability of all three strains, but 
significant differences were not found until the concentration of farnesol exceeded 
150µM.  At 300µM concentrations of trans,trans-farnesol, both cdr4-/- and als6-/- strains 
were able to significantly attach with a higher percentage, 77% and 83%, than that of 
the SC5314 control which only had about 69% of attached cells (Figure 3.2).  HSL, at 
both 50µM and 200µM, caused a decrease in wild-type SC5314 attachment, while both 
cdr4-/- and als6-/-, surprisingly, had equal or greater attachment than that of the wild-
type SC5314 as well as near the levels of the molecule free media only controls (Figure 
3.2).  Indole, at all concentrations, decreased attachment for all three strains with no 
significant difference in their ability to adhere to polystyrene (Figure 3.2).  LPS had 
minimal effect on all three strains with each retaining their ability to attach near the 
levels of the untreated controls (Figure 3.2).  Finally, trans-2-decenoic acid, at the 
highest concentration of 25µM, resulted in the SC5314 having about 63% of the 
attached cells while cdr4-/- and als6-/- had 78% and 85% respectively (Figure 3.2). 
These results indicate that trans,trans-farnesol, HSL, trans-2-decenoic acid do not 
dramatically inhibit the ability of cdr4-/- and als6-/- strains to adhere to polystyrene.  
However, the reduction in adherence is slightly above wild type suggesting that the 
initial stage of biofilm adherence is minimally compromised by these molecules.  The 
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similar molecular structure of trans, trans-farnesol, trans-2-decenoic acid, and HSL 
could indicate that attachment to abiotic surfaces is impacted by Cdr4p and Als6p in 
response to molecules with the shared 12 carbon backbones and not the lipid 
polysaccharide structure of LPS or the aromatic structure of indole.   
 
Figure 3.2. Effects of farnesol and bacterial molecules on attachment of C. 
albicans SC5314 wild-type, cdr4-/-, and als6-/-strains to abiotic surfaces. 
Strains were grown in 96 well polystyrene plates under hyphal inducing conditions 
(pH7.5, 37°C, M199 media) for 1.5 hours with or without the addition of: 
trans,trans-farnesol (FRN), 3-oxo-C12-homoserine lactone (HSL), indole (IND), 
lipopolysaccharide (LPS), and trans-2-decenoic acid (TDA).  Attachment was 
determined by crystal violet staining and quantified by absorbance.  Asterisk 
denotes statistical significance (p<0.05) compared to matched SC5314 wild-type 
control as determined by student’s t-test.  Control SC5314 without added bacterial 
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molecules represents 100% attachment and all other values are determined in 
proportion to this value. Mean percentage and standard deviation are shown.  
Each condition was performed in triplicate and is the result of three independent 
trials. 
 
After determining the effects on attachment by trans,trans-farnesol, indole, trans-2-
decenoic acid, HSL, and LPS, we tested the ability of cdr4-/- and als6-/- strains to form 
biofilms in the presence of these molecules.  The effect of increasing concentrations of 
these molecules on C. albicans wild type and null strains in regards to biofilm growth 
are shown in Figure 3.3 and Supplementary Figure 3.3.  Again, because values were 
obtained in respect to optical density, the untreated SC5314 control was designated as 
100% biofilm formation and all other percent values were compared in relation to this 
optical density value.   All three strains had near equal ability to form dense biofilms 
under control conditions by 48 hours.  No statistical difference was found between the 
wild-type SC5314 control and cdr4-/- and als6-/- strains at trans,trans-farnesol 
concentrations of 50 and 150µM.  However, at the 300µM concentration of trans,trans-
farnesol there was an increase in total biofilm mass by the cdr4-/- (81%)and als6-/- 
(80%) strains over wild-type SC5314 (65%) (Figure 3.3).  At the 200µM concentration 
of HSL wild-type SC5314 was reduced to 85%% while cdr4-/- (98%) and als6-/- (95%) 
had significantly more biofilm mass which were near the untreated control levels. 
(Figure 3.3).  Indole added at the highest concentration, 4mM, was able to suppress 
biofilm formation of wild-type SC5314 to 77%  and only als6-/- (83%) was able to 
significantly increase biofilm formation over the wild-type SC5314 control (Figure 3.3).  
LPS minimally reduced biofilm mass of all three strains, but cdr4-/- (98%) and als6-/- 
(98%) had an increased biofilm mass over wild-type SC5314 (91%) (Figure 3.3).  
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Lastly, there was no statistical difference among the three strains when trans-2 
decenoic acid was added with all three strains having equal reduction in biofilm mass 
(Figure 3.3).  
 
Figure 3.3. Effects of farnesol and bacterial molecules on biofilm formation of C. 
albicans SC5314 wild-type, cdr4-/-, and als6-/- strains. Strains were grown in 96 
well polystyrene plates under hyphal inducing conditions (pH7.5, 37°C, M199 
media) for 1.5 hours then fresh media was added with or without the addition of: 
trans,trans-farnesol (FRN), 3-oxo-C12 homoserine lactone (HSL), indole (IND), 
lipopolysaccharide (LPS), and trans-2-decenoic acid (TDA).  Biofilm formation was 
determined by crystal violet staining and quantified by absorbance.  Asterisk 
denotes statistical significance (p<0.05) compared to matched SC5314 wild-type 
control as determined by student’s t-test.  Control SC5314 without added bacterial 
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molecules represents 100% biofilm formation and all other values are normalized 
to this value. Mean percentage and standard deviation of triplicate trials are 
shown. 
 
In both the attachment and biofilm assays, with a few exceptions, only the highest 
concentrations of trans, trans-farnesol and bacterial molecules were able to elicit a 
statistically significant difference.  This result is supported by a previous study that 
looked at attachment time, inhibition of biofilm formation, and increasing concentrations 
of farnesol [42].  This earlier study determined that high concentrations of farnesol 
(300μM) were required to inhibit C. albicans biofilm formation and that attachment time 
also played a factor in this process [42].  This is likely due to the community lifestyle 
where C. albicans biofilms have been shown to be up to 2000 times more resistant to 
antifungals [43].  With the exception of farnesol, none of the molecules tested were able 
to dramatically decrease attachment or biofilm formation among any of the strains 
tested.  This may be the result of two factors.  First, due to the complexity that 
communities of C. albicans encompass, it may be that higher concentrations are 
required to produce a reduction in attachment and biofilm formation.  It has been well 
documented that planktonic cells are more susceptible to antifungals than stationary 
cells [43].  Secondly, it has been shown that C. albicans cells locked into the yeast form 
still retain the ability, albeit at a reduced capacity, to attach and form biofilms [44].  The 
study of C. albicans in the context of polymicrobial interactions is definitely one with 
numerous factors to consider.  In a series of studies on the effect of LPS on C. albicans 
attachment and biofilm growth, Bandara et al. [45-47] established that the bacterial 
species the LPS was derived from, the amount of time, the concentration of LPS, the 
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species of Candida, and even a Candida strain dependency were all factors that 
influenced the increase, decrease, or no effect on attachment and formation of Candida 
biofilms. 
Conclusions  
Overall, we have begun to explore the impact that C. albicans genes play in Candida-
bacterial interactions and their potential role in C. albicans quorum sensing.  Though 
this has been a limited study with two genes of interest, there are several that we 
identified previously [24] that remain to be characterized in the future. Furthermore, this 
lays the groundwork into deciphering C. albicans-bacterial interactions at the genetic 
level.  For example, can we alter the bacterial molecules that inhibit C. albicans 
filamentation and use them for new antifungal therapies alone or in addition to current 
treatments?  Further work needs to establish the mechanisms of action that bacterial 
molecules have on C. albicans as well as further characterization of their production 
when C. albicans and different bacteria are present in co-culture. 
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CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTION 
Use of Genetic Library Screening in Candida-Bacterial Interactions 
The use of genetic library screens in microbiological research has been 
instrumental in determining numerous attributes of microorganisms and C. albicans is 
no exception.  More specifically, the use of a Tn7 transposon as an insertional mutagen 
to identify genes instrumental in specific functions of C. albicans is becoming more 
prevalent as a research tool.  The original Tn7 library implemented in our research was 
derived from a study that screened for genes involved in C. albicans filamentous growth 
(Uhl et al. 2003).  Tn7 library screenings have also been used to identify genes involved 
in the C. albicans RAM signaling pathways of filamentation (Bharucha et al. 2011), and 
haploinsufficiency has aided in observable changes in phenotypes for other studies 
including drug susceptibility targets (Oh et al. 2010).  The results from our study 
demonstrate that a Tn7 transposon insertion library can successfully be used to identify 
genetic elements involved in Candida-bacterial interactions.   
Defining Signaling Pathways in Candida-Bacterial Interactions 
The signaling cascade of events involved in C. albicans regulation of morphology 
in response to bacteria and bacterially derived molecules is relatively unknown.  
Presumably, these signaling pathways could coincide with some of the same elements 
that control morphology as directed by the autoregulatory molecule farnesol.  However, 
given the diverse array of bacteria that C. albicans contacts within the shared habitat of 
the human body a number of questions arise:  1) Are the genetic pathways that control 
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morphology the same, share components of, or completely different between farnesol 
response and bacterial response?  2) Are there global signaling pathways in C. albicans 
in response to all bacteria or are they specialized? For example, do Gram-positive 
bacteria use the same pathways as Gram-negative or entirely different pathways?  3) 
Do those bacteria that have antagonistic relationships with C. albicans activate separate 
pathways than those that share mutualistic or symbiotic relationships?  4) Are there 
human host factors that influence or exacerbate these Candida-bacterial interactions? 
5) How do these polymicrobial interactions alter the host immune response? Bacteria 
exposure elicits a different immune response from that of Candida, and evidence exists 
showing that combined Candida-bacterial exposure causes a host response directed at 
one microorganism while the other may benefit from a less specific host response 
(Allard et al. 2009).  Polymicrobial exposure also causes distinct proinflammatory 
responses compared to monomicrobial exposure as well as numerous documented 
examples of increased mortality of coinfection where single species infection cause no 
mortality (Carlson 1982; Klaerner et al. 1997; Peters and Noverr 2013). 
Polymorphism as a Target for C. albicans Treatments 
The interest of C. albicans polymorphism as a virulence trait and the role it plays 
in pathogenesis is evident in the escalation of research involving the understanding of 
the regulation of this shift, as well as investigation of therapeutics aimed at inhibiting this 
trait.  Understandably, development of pharmological interventions that could block this 
transition is very attractive in that they could hinder Candida overgrowth, reduce 
invasiveness, and diminish biofilm capacity.  The importance of the 2 dominant 
morphologies, yeast and hyphae, and their role in infection has been and continues to 
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be ardently debated.  Typically, yeast cells are associated with moderate attachment 
ability and little to no invasiveness and host damage.  Thus, yeast cells are associated 
with initial attachment and dissemination.  Alternatively, the hyphal form is believed to 
have strong adhesive ability, invasiveness, increased damage, dissemination across 
epithelial cells, and host immune evasion.  While hyphal cells can be found in tissue, 
there are reports that yeast cells can be found as well.  Likewise, commensal C. 
albicans are believed to be of yeast morphology, while the invasive hyphae are believed 
to be involved in infections (Cheng et al. 2012).  In reality, it is the ability to express both 
morphologies that leads to full virulence.  This is evident by 2 lines of evidence.  First, 
biofilms of C. albicans that are locked into either morphological form are severely 
attenuated in their growth and drug resistance (Baillie and Douglas 1999).  Second, 
Candida locked into either morphological form are avirulent (Baillie and Douglas 1999).  
Inhibiting polymorphism has been successfully used to treat Candidiasis in mouse 
models (Ramage et al. 2002).  Targeting the virulence factors of C. albicans may prove 
more effective and sustainable as a treatment option given that C. albicans cells remain 
viable, thus, there are limited selective pressures that would promote or favor drug 
resistance.  However, only in obtaining a thorough understanding of the signaling 
events and genetic controls of polymorphism and QS combined will there be effective 
treatment options based on such.   
Quorum Sensing as a Target for C. albicans Treatment 
Farnesol appears to be a tempting mode of treating Candida infections as it 
governs the morphogenic transition.  However, the application of farnesol in vivo has 
garnered mixed results.  Farnesol has been shown in mouse models to provide 
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protection in oral candidiasis (Hisajima et al. 2008).  This has also been observed in 
human cells where farnesol exposure increased host immune response as well as 
inhibited morphogenesis (Saidi et al. 2006; Décanis et al. 2009).  The effects of farnesol 
on systemic candidiasis were less favorable as a treatment option.  Mice in a systemic 
candidiasis model that were administered farnesol had increased mortality and there 
was an inhibition of immune function that made the mice more vulnerable to candidiasis 
(Navarathna et al. 2007).  In vitro, farnesol is able to inhibit Candida biofilms as well as 
cause apoptosis in Candida cells (Ramage et al. 2002; Shirtliff et al. 2009). 
Quorum Sensing as a Method of Controlling Polymicrobial Infections 
Locking Candida into the yeast form could prove valuable in combating 
polymicrobial infections.  It is well documented that a number of bacteria preferentially 
associate with the hyphae of C. albicans and in some instances are unable to attach to 
the yeast form (Hogan and Kolter 2002; Tampakakis et al. 2009).   Locking C. albicans 
into the yeast form could reduce the colonization of bacteria and possibly diminish the 
development of mixed species biofilms.  Again, locking C. albicans into the yeast form 
produces minimal biofilms that would also reduce the ability of Candida-bacterial 
biofilms from becoming established (Baillie and Douglas 1999).  Candida-bacterial 
biofilms are more resistant to antifungals and antibiotics so this would reduce the 
burden of long courses of treatment with high concentrations of antimicrobials, lead to 
fewer instances of polymicrobial biofilms, as well as reducing the reservoir of infection.  
In vitro testing of farnesol on bacterial biofilms has shown to work synergistically with 
antibiotics, inhibit biofilm formation, and compromise cell integrity (Meiller et al. 2006; 
Cugini et al. 2007; Peleg et al. 2008).  Farnesol appears to have the ability to inhibit 
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both the attachment and maturation phases of bacterial biofilm growth as well as 
reduction in preformed biofilms  and causes biofilm detachment (Unnanuntana et al. 
2009; Cerca et al. 2012).  
The targeting of C. albicans virulence factors, such as polymorphism, holds great 
potential in both the treatment of monospecies C. albicans infections as well as 
polyspecies Candida-bacterial infections.  With the increases in drug resistance, the 
large percentage of polymicrobial infections affecting patients, and the limited number of 
antifungals there is a recognizable need for new applications to combat C. albicans.  A 
significant key to advancing new therapeutics may be the molecules and metabolites 
microorganisms use, such as QS, during their own plight to survive when challenged by 
other microorganisms. 
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APPENDICIES 
 
Supplemental Data 
 
Supplementary Table 2.1.  Genetic elements identified from the C. albicans Tn7 insertion library screen 
Systematic Standard Tn7 Library Predicted/Known Predicted/Known 
Name Name Location Number Biological Function Protein Localization 
orf19.10 ALK8 ORF 166a9 Enzymatic activity Endoplasmic Reticulum 
orf19.23 RTA3 5’ of ORF 4g8 Transport Membrane 
orf19.344 ------- 3’ of ORF 181a2 Unknown Unknown 
orf19.346 ------- 3’ of ORF 158c12 Enzymatic activity Cytoplasm 
orf19.470* ------- ORF 133f7 Transcription DNA binding complex 
orf19.511 ------- 5’ of ORF 125c6 Enzymatic activity Cytoplasm 
orf19.517 HAP31 5’ of ORF 159f4 Transcription DNA binding complex 
orf19.526 NHP2 ORF 128d3 RNA processing RNA binding complex 
orf19.536 ------- 3’ of ORF 122e7 Transcription DNA binding complex 
orf19.860 BMT8 3’ of ORF 129a8 Cell wall associated Unknown 
orf19.978 BDF1 5’ of ORF 177c11 Transcription Chromosome 
orf19.999 GCA2 ORF 133d12 Enzymatic activity Endoplasmic Reticulum 
orf19.1040 MAD2 ORF 125h1 Cell cycle Chromosome 
orf19.1110 ------- 5’ of ORF 138d11 Enzymatic activity Cytoplasm 
orf19.1201 ------- 5’ of ORF 184e2 RNA processing Mitochondria 
orf19.1368 ------- 3’ of ORF 75b1 Unknown Unknown 
orf19.1401 EAP1 5’ of ORF 42f9 Adhesion Membrane 
orf19.1523 FMO1 ORF 180c12 Enzymatic activity Unknown 
orf19.1693 CAS4 ORF 154d11 Signaling Cell tip 
orf19.1728 ------- ORF 162f11 Unknown Unknown 
orf19.1759 PHO23 ORF 134b7 Transcription RNA binding complex 
orf19.1911 PGA52 ORF 134c6 Cell wall associated Membrane 
orf19.1941 NUF2 5’ of ORF 135b3 Cell cycle Chromosome 
orf19.1996* CHA1 ORF 70a7 Amino acid synthesis Unknown 
orf19.2038 ------- 3’ of ORF 178a8 Unknown Unknown 
orf19.2081 POM152 ORF 75d8 Transport Membrane 
orf19.2106 ------- ORF 160b6 Unknown Unknown 
orf19.2114 ------- ORF 134g2 Enzymatic activity Nucleus 
orf19.2138 ILS1 ORF 49c11 RNA processing Cytosol 
orf19.2290 TOR1 ORF 98f7 Signaling TOR complex 
orf19.2356 CRZ2 ORF 74e11 Transcription Intracellular 
orf19.2417* SMC5 ORF 61e7 DNA repair Nucleus 
orf19.2423 ZCF11 ORF 149b7 Transcription Nucleus 
orf19.2495 GSL1 ORF 93h4 Cell wall associated Membrane 
orf19.2524 MGE1 5’ of ORF 156f2 Transport Mitochondria 
orf19.2579 ------- ORF 184c4 DNA binding Chromosome 
orf19.2929 GSC1 3’ of ORF 156b8 Cell wall associated Membrane 
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orf19.2982 ------- ORF 69g10 Autophagy Unknown 
orf19.2989 GOR1 3’ of ORF 96g2 Enzymatic activity Nucleus 
orf19.3001 TEM1 ORF 134c1 Cell cycle Spindle pole body 
orf19.3087.2 ------- ORF 161e5 Unknown Unknown 
orf19.3100 ------- 3’ of ORF 156f1 Unknown Unknown 
orf19.3124 ------- ORF 131a2 RNA binding Ribosome 
orf19.3394 ------- ORF 134d10 Unknown Membrane 
orf19.3519 SUA72 ORF 145c6 Transcription Unknown 
orf19.3643 ------- ORF 131b1 Unknown Intracellular 
orf19.3730 ------- ORF 120c7 Protein processing Endoplasmic Reticulum 
orf19.3767 ------- ORF 158c10 Protein processing Golgi 
orf19.3791 FGR10 ORF 143h2 Proteolysis Cytosol 
orf19.4018* ------- ORF 116b7 RNA binding Ribosome 
orf19.4023 MRP2 ORF 143d4 Translation Ribosome 
orf19.4054 CTA24 ORF 125c9 Transcription Unknown 
orf19.4086 ------- 3’ of ORF 126g4 Protein processing Cytoplasm 
orf19.4099 ECM17 ORF 95b6 Amino acid synthesis Cytosol 
orf19.4112 ------- 3’ of ORF 135c1 Enzymatic activity Cytosol 
orf19.4119 SPO72 ORF 175e7 Autophagy Membrane 
orf19.4176 ------- ORF 147h9 Translation Ribosome 
orf19.4246 ------- ORF 68d3 Enzymatic activity Unknown 
orf19.4261 TIF5 5’ of ORF 127f6 Translation Ribosome 
orf19.4263 ------- ORF 173g2 Unknown Unknown 
orf19.4412 ------- ORF 120d11 DNA repair Chromatin 
orf19.4610 ------- ORF 161g5 Proteolysis Unknown 
orf19.5076 CDR4 5’ of ORF 35d10 Transport Membrane 
orf19.5101* CCR4 5’ of ORF 133d6 Transcription DNA binding complex 
orf19.5144 PGA28 5’ of ORF 97h8 Adhesion Cell surface 
orf19.5169* ------- 5’ of ORF 94b8 Enzymatic activity Nucleus 
orf19.5212 ------- ORF 81c7 Protein processing Unknown 
orf19.5407* SOF1 ORF 68e6 Ribosomal associated Ribosome 
orf19.5485 MEC3 ORF 134f5 DNA repair DNA binding complex 
orf19.5506 PLC1 ORF 134g3 Enzymatic activity Cytoplasm 
orf19.5519 GCV1 5’ of ORF 162d1 Enzymatic activity Mitochondria 
orf19.5665 ------- ORF 134d9 Enzymatic activity Unknown 
orf19.5799 ------- ORF 170c3 Unknown Cytoplasm 
orf19.5813 ------- 3’ of ORF 125h3 Adhesion Nucleus 
orf19.5897 ------- 5’ of ORF 168h5 Unknown Cytosol 
orf19.5902* RAS2 ORF 109b6 Signaling Membrane 
orf19.5938 SEN1 ORF 134b8 RNA processing RNA binding complex 
orf19.6082 ------- ORF 175a5 Protein processing Endoplasmic Reticulum 
orf19.6323 HPA2 5’ of ORF 88a4 Amino acid synthesis Nucleus 
orf19.6488* ------- ORF 72d12 Unknown Unknown 
orf19.6592 ------- 3’ of ORF 176f2 Transport Membrane 
orf19.6722* ------- ORF 78e8 DNA repair Cytosol 
orf19.6736 ------- 5’ of ORF 78g8 RNA repair Mitochondria 
orf19.6747 ------- ORF 175c8 Transport Cytoplasm 
orf19.6785 RPS12 ORF 189h2 Ribosomal associated Ribosome 
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*denotes gene was identified in multiple candidates. Library numbers designate the plate number and 
well number location of the candidate strain so that, if requested, individual candidates can be located. 
Supplementary Table 2.2.  Major repeat sequences identified from the C. albicans Tn7 library screen 
Major repeat sequence Library number  
MRS-R 71a3, 72f5 
MRS-1 71c7, 76a5, 134c9, 134h11, 161a10 
MRS-2 56a9, 70a3, 81a4, 81f9, 120h2, 124g9, 129f3, 132c7, 133b6, 134a7, 134b3,  
 134c10, 136f9, 142e7, 143d10, 151b11, 163a4, 165d11 
MRS-4 113f8, 123e10, 133g9, 134e9, 165e11 
MRS-6 133c5, 119g3, 144g9 
MRS-7a 42f11, 124d4, 124g12, 138d12 
MRS-7b 71b11, 176g8 
 
Supplementary Table 2.3. Non-coding/unannotated transcripts identified in C. albicans library screen 
Transcript name Reference Library number 
Novel-Ca21chrR-009  Bruno et al. 145c8 
Novel-Ca21chrR-023 Bruno et al. 134b12 
Novel-Ca21chrR-093* Bruno et al. 12e3 
Novel-Ca21chrR-094 Bruno et al. 75e5 
Novel-Ca21chrR-100 Bruno et al. 182c1 
Novel-Ca21chr2-037 Bruno et al. 134g1 
Novel-Ca21chr7-001 Bruno et al. 148b5 
TFRW255 Sellam et al. 135b6 
orf19.6931 ------- ORF 70d10 RNA processing RNA binding complex 
orf19.6968* ------- ORF 78g11 Unknown Unknown 
orf19.6987 DNM1 ORF 76a4 Protein processing Mitochondria 
orf19.7085 ------- 3’ of ORF 176h6 Unknown Unknown 
orf19.7108 RPS18 3’ of ORF 187a10 Ribosomal associated Ribosome 
orf19.7130 ------- ORF 125h4 Unknown Unknown 
orf19.7152 ------- 5’ of ORF 185g12 Enzymatic activity Mitochondria 
orf19.7232 IRR1 3’ of ORF 94h8 Cell cycle Nucleus 
orf19.7301 ------- ORF 134d4 DNA binding Unknown 
orf19.7313 SSU1 5’ of ORF 168e11 Transport Membrane 
orf19.7342 AXL1 ORF 169d5 Proteolysis Unknown 
orf19.7358 ------- 3’ of ORF 98d10 Protein processing Mitochondria 
orf19.7413 MMS21 5’ of ORF 176a10 DNA repair DNA binding complex 
orf19.7414* ALS6 5’ of ORF 49b8 Adhesion Cell surface 
orf19.7483 CRM1 ORF 149a8 Transport Nucleus 
orf19.7512 ------- ORF 131a3 Enzymatic activity Unknown 
orf19.7565 GNP3 ORF 99e9 Transport Membrane 
orf19.7567 ------- SPT7ORF 156e4 Unknown Unknown 
orf19.7572*  ORF 42h5 Transcription Mitochondria 
orf19.7579 FGR34 ORF 151a9 Unknown Unknown 
orf19.7657 POP3 ORF 90c8 RNA processing RNA binding complex 
orf19.7667* IAH1 5’ of ORF 131c7 Enzymatic activity Cytoplasm 
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TF1W4 Sellam et al. 159e10 
TF1W160 Sellam et al. 98b5 
TF3C2 Sellam et al. 61e3 
TF3C162 Sellam et al. 183h1 
TF4C158* Sellam et al. 134f6 
TF5C101 Sellam et al. 76f10 
TF5W116 Sellam et al. 134c3 
TF5W130 Sellam et al. 166e9 
TF7C126 Sellam et al. 95h6 
TF7W6 Sellam et al. 88d10 
*denotes transcript was identified in multiple candidates 
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Supplementary Figure 2.1.  Phenotypes observed when SC5314, library 
transposon candidates, heterozygous and homozygous deletion strains grown in 
liquid culture (37°C) with bacteria or spent media. A) C. albicans strains with M199 
filamentation control and coculture with E. coli, P. aeruginosa, and S. aureus.  
Magnification 400x; B) C. albicans strains with M199 filamentation control and culture in 
spent media E. coli, P. aeruginosa, and S. aureus. Magnification 400x. 
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Supplementary Figure 2.2.  C. albicans CDR4 gene expression when cocultured with 
a media only control, E. coli, P. aeruginosa, or S. aureus.  ENO1 control is also shown. 
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Supplementary Figure 3.1.  Individual graphs of SC5314 wild type, cdr4-/-, and als6-/- cell 
morphology in the presence of varying concentrations:  (A) competence stimulating peptide-1 
(CSP1), (B) 1-dodecanol, (C)trans,trans-farnesol, (D) 3-oxo-C12-homoserine lactone (HSL), (E) 
indole, (F) lipopolysaccharide (LPS), (G) phenazine, (H) pyocyanin, and (I) trans-2-decenoic acid 
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Supplementary Figure 3.2.  Individual graphs of SC5314, cdr4-/-, and als6-/- attachment in the 
presence of varying concentrations:  (A) trans,trans-farnesol, (B) 3-oxo-C12-homoserine lactone 
(HSL) , (C) indole, (D) lipopolysaccharide (LPS) , and (E) trans-2-decenoic acid. 
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Supplementary Figure 3.3.  Individual graphs of SC5314, cdr4-/-, and als6-/- biofilm formation 
in the presence of varying concentrations:  :  (A) trans,trans-farnesol, (B) 3-oxo-C12-homoserine 
lactone (HSL) , (C) indole, (D) lipopolysaccharide (LPS) , and (E) trans-2-decenoic acid. 
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